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Abstract 
To better understand the role of cholinergic signaling in specific regions of the brain, several 
genetically modified mice targeting the vesicular acetylcholine transporter (VAChT) gene 
have been generated (Prado et al., 2006; Guzman et al., 2011; de Castro et al., 2009). VAChT 
stores acetylcholine (ACh) in synaptic vesicles, and changes in this transporter expression 
directly interferes with ACh release. Here, we use a mouse line with VAChT deletion in the 
pedunculopontine tegmental nucleus (PPT) to evaluate the consequences of decreased 
cholinergic signaling from the PPT in vivo. Based on the efferent connectivity from the PPT, 
our hypothesis is that decreased cholinergic signaling from the PPT will affect specific 
behavioural outputs. It was determined that these mice have strong deficits in spatial and 
goal-directed learning as well as an antidepressive-like phenotype. Mild phenotypes include 
gait abnormalities, anxiety-like behavior and decreased compulsivity. Improving our 
understanding of cholinergic signaling from the PPT and how it relates to behavioural 
abnormalities may lead to the development of novel treatments for the symptoms of 
neurological diseases such as PD and PSP, which show degeneration of PPT neurons (Hirsch 
et al. 1987). 
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Chapter 1  
1 The Cholinergic System 
Acetylcholine (ACh) was the first neurotransmitter to be discovered. This 
neurotransmitter, described by Otto Loewi in 1921 (Mesulam et al., 1984), is one of the 
major neurotransmitters in the central nervous system (CNS), and it is also the main 
neurotransmitter in the peripheral nervous system (PNS) In the CNS, there are two 
primary sources of acetylcholine: local interneurons or projection neurons that innervate 
distal targets. Tonically active cholinergic interneurons are located mainly in the dorsal 
striatum and the nucleus accumbens (reviewed by Picciotto et al., 2012). Projection 
neurons originate mainly from two brain regions: the pedunculopontine nucleus and 
lateral dorsal tegmentum nuclei (together known as the mesopontine tegmentum) located 
in the brainstem (Mesulam et al., 1995), and also from the basal forebrain (Zaborszky et 
al., 2008).  Mesulam and colleagues (1984) utilized immunohistochemistry to divide all 
the cholinergic neurons into six major categories based on their connectivity patterns in 
the rat and primate brain. The Ch1 and Ch2 groups of neurons provide the major 
cholinergic input to the hippocampus. The Ch3 group project to the olfactory bulb and 
the Ch4 group of cholinergic neurons topographically innervate the entire neocortical 
mantle. The Ch5 and Ch6 groups are the major source of cholinergic innervation of the 
thalamus. Each of the Ch categories are also delineated by distinct nuclear boundaries 
(Mesulam et al., 1984). 
ACh can act as a neuromodulator in the CNS by changing the state of neurons so 
their response to subsequent stimulation is altered (Picciotto et al., 2012). The actions of 
ACh are mediated through receptors on a large number of neuronal subtypes, both pre- 
and post-synaptically.  These receptors fall into two classes: metabotropic acetylcholine 
receptors (mAChRs) and ionotropic nicotinic acetylcholine receptors (nAChRs) 
(reviewed by Picciotto et al., 2000; Wess 1996). 
There are five unique subtypes of the mAChR receptor (M1-M5), all of which are 
G-protein-coupled receptors (Wess 1996). mAChR are linked to either Gq or Gi/o type G-
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proteins. The M1, M3 and M5 receptors are linked to the Gq protein, whereas the M2 and 
M4 receptors are coupled to Gi/o type G-proteins (Wess 1996). The Gq proteins activate 
phospholipase C, while Gi/o proteins negatively couple to adenylate cyclase (Wess 1996).  
The nAChRs are non-selective cation channels with a molecular mass of 290 kDA 
that cause depolarization of the neuron (Changeux et al., 1998; Picciotto et al., 2001). 
These allosteric receptors respond to ACh and nicotinic agonists by quickly (μs to ms 
range) opening the channel that is permeable to Na+, K+ and sometimes Ca2+ ions 
(Changeux and Edelstein, 2005). nAChRs are transmembrane oligomers made up of five 
subunits symmetrically arranged around a central ionic channel. The combinations of 
subunits have distinct expression patterns in specific neuronal types (Gotti et al., 2007). 
The nAChR subunits, encoded by 12 genes, have been classified into two subfamilies of 
proteins: nine α-subunits (α2-α10) and three β–subunits (β2-β4) (Gotti et al., 2007). The 
nAChRs can also be classified based on their pharmacological properties into groups of 
receptors that are sensitive to α-Bungarotoxin (homomeric and heteromeric receptors 
consisting of α7, α8, α7-8, α9 and/or α10 subunits) and receptors that are insensitive to α-
Bungarotoxin (heteromeric receptors consisting of α2-α6 and β2-β4 subunits) (Gotti and 
Clementi, 2004). The various nAChRs subunit combinations differ in their cellular 
localization in the brain. There are two main types of nAChRs in the brain: the α7 homo-
oligomer and the α4β2 hetero-oligomer (Changeux and Edelstein, 2005). The α7 nAChR 
is characterized by fast activation and desensitization, a low affinity for ACh and a high 
Ca2+ permeability (Gotti et al., 2007) and it is located presynaptically (Jones and 
Wonnacott, 2004). The α4β2 nAChR is characterized by a low desensitization, a high 
affinity for ACh and nicotinic agents, and it is strongly upregulated by nicotine exposure 
(Changeux and Edelstein, 2005, Picciotto et al., 2001; Reviewed by Buisson and 
Bertrand, 2002). β2-containing nAChRs and α7 nAChRs are widely expressed in the 
brain (Gotti et al., 2007) whereas other subtypes have a more restricted expression. 
Interestingly, chronic exposure of nAChRs to ACh or nicotinic agonists results in a 
gradual decrease in the rate of response to the ligand and ultimately a high-affinity, 
desensitized, closed state of the receptor (Changeux and Edelstein, 2005).  
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1.1 Acetylcholine 
To synthesize ACh, the precursor choline must be brought into the cell by the high-
affinity choline transporter (CHT1) or SLC5A7 (solute carrier family 5 member 7) 
(reviewed by Ribeiro et al., 2006). Once in the cytoplasm of nerve terminals, choline is 
used to synthesize ACh by the enzyme choline acetyltransferase (ChAT) (Prado et al., 
2002; Parsons 2000). The vesicular ACh transporter (VAChT) or SLC18A3 (solute 
carrier family 18 member 3) loads ACh into synaptic vesicles (Prado et al., 2002; Parsons 
2000). Thousands of molecules of ACh are packaged into a synaptic vesicle to form a 
quantum so ACh can be released by exocytosis.  
1.2 The High-Affinity Choline Transporter 
In the CNS, cholinergic neurons are incapable of synthesizing ACh de novo, so their 
ability to signal with this neurotransmitter depends on the neurons ability to uptake 
choline (Tucek 1985). To do this, neurons have two carrier-mediated transport systems 
for choline uptakewhich are located in the pre-synaptic nerve terminal (Haga 1971). The 
concentrations of available choline in the extracellular space determines which system is 
used for choline transport. At high concentrations, choline is transported into the neuron 
by a low-affinity system that is Na+-independent, whereas at low concentrations, the 
high-affinity Na+-dependent system predominates. The high-affinity transporter is 
distinguished from the low-affinity transporter by its inactivation by hemicholinium-3 as 
well as its dependence on extracellular Na+ and Cl- levels (Yamamura and Snyder, 1972). 
Okuda and Haga (2000) were the first to isolate the cDNA encoding CHT1 in the rat 
brain. CHT1 is unique to cholinergic neurons because choline is specifically converted 
into ACh only when the high-affinity transporter is used, whereas choline taken up with 
the low-affinity transporter is not converted to ACh (Yamamura and Snyder, 1972). 
Choline uptake is believed to be the rate-limiting step in ACh synthesis (Okuda and 
Haga, 2000). In order to maintain ACh synthesis, CHT1 is used to recover choline from 
the synapse after ACh hydrolysis by AChE (Birks and MacIntosh, 1961). While CHT1 
function is predominantly at the plasma membrane, it has been demonstrated that this 
protein is located on the plasma membrane, as expected, but also on presynaptic vesicles 
that were positive for VAChT (Ribeiro et al., 2003; Ferguson et al., 2003).  
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Depolarization leads to an increase in the Vmax for high-affinity choline uptake as well as 
an increase in the density of CHT proteins in the plasma membrane (Ribeiro et al., 2003; 
Ferguson et al., 2003). These results suggest that large intracellular stores of CHT1 are 
available to be delivered to the plasma membrane when the rate of ACh release is 
increased.  
1.3 The Enzyme Choline Acetyltransferase 
ChAT is a single-stranded globular protein that mediates the transfer of an aceyl 
group from acetyl coenzyme A (acetyl-CoA) to choline at the synaptic terminals of 
cholinergic neurons to generate ACh (Oda 1999). The enzyme is synthesized in the 
perikaryon of cholinergic neurons and is transported to the nerve terminal through 
axoplasmic flow (Oda 1999). There, it can exist in two forms: a soluble form (80-90% of 
total enzyme activity) and an insoluble membrane-bound form (10-20% of total enzyme 
activity). Smith and Carroll (1993) demonstrated that in the rat hippocampal tissue, 
ChAT can be fractionated with synaptic vesicles, suggesting that a portion of the 
membrane-bound ChAT may be attached to cholinergic synaptic vesicles by a glycosyl-
phosphatidylinositol anchor. 
Genomic studies by Misawa et al. (1992) have identified a number of ChAT mRNA 
species that are transcribed from different promoter regions and produced by differential 
splicing. Interestingly, the genomic structure of ChAT is unique in addition to being 
complex: the VAChT gene is embedded in the first intron of the ChAT gene (Erickson et 
al., 1994), which was subsequently named the “cholinergic gene locus” (Erickson et al., 
1994; Eiden 1998).  Inside the first intron there is a 1590 bp open reading frame (ORF) 
that encodes the VAChT protein, which is in the same transcriptional orientation as the 
ChAT gene (Bejanin et al., 1994). Alternative splicing of this single precursor mRNA 
gives rise to two proteins involved in sequential biochemical steps: synthesis and storage 
of ACh (Alfonso et al., 1994). Several studies have confirmed the coexpression of the 
ChAT and VAChT proteins. Benjanin et al. (1994) investigated whether signals (such as 
retinoic acid) that induced ChAT gene expression also induced VAChT gene expression, 
and found that the agents increased the mRNA and protein levels of both products, 
indicating a common regulatory mechanism of their transcription.  
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In Drosophila, VAChT and ChAT transcripts contain the same complete first exon 
and use a common promoter upstream of the ChAT first exon (Kitamoto et al., 1998). 
However, in vertebrates, the expression mechanisms are far more complicated. There are 
several different promoters in the 5’ region of the cholinergic gene locus: a common 
promoter for R-type ChAT and VAChT mRNA (upstream of ChAT exon R), two 
promoters for VAChT mRNA between ChAT exon R and the VAChT ORF, and one 
promoter for M-type ChAT mRNA between ChAT exons N and M (Mallet et al., 1998). 
The different ChAT mRNA transcripts are summarized in Figure 1.  
 
Figure 1. The vertebrate cholinergic gene locus and the five ChAT mRNA 
transcripts produced by differential splicing. P = promoter. Adapted from Mallet et 
al. 1998. 
  
The primary structure for ChAT reveals a number of putative phosphorylation sites 
and short-term post-translational regulation of the ChAT enzyme by protein kinases has 
been demonstrated. For instance, Dobransky et al. (2001) demonstrated that 
phosphorylation of serine 440 by protein kinase C (PKC) increased enzyme activity, and 
may also alter subcellular localization (Dobransky et al., 2001). It is likely that 
phosphorylation influences whether the protein will be soluble or membrane-bound and 
as well as the enzyme’s catalytic activity, which in turn alters the biosynthesis of ACh 
(Cooke and Rylett, 1997).  
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1.4 The Vesicular Acetylcholine Transporter 
VAChT is also critical to the functioning of the cholinergic system as it is required 
for ACh storage. The importance of VAChT is emphasized by VAChT knockout mice 
that cannot survive after birth due to respiratory dysfunction and atrophied skeletal 
muscle (de Castro et al., 2009).  The consequences of reduced VAChT expression have 
been demonstrated using genetically modified mice with a knockdown of VAChT gene 
expression. The homozygous VAChT knockdown mice (VAChT-KDHOM) have a 62% 
decrease in VAChT protein levels and present severe muscular fatigue and cognitive 
alterations. However, heterozygous VAChT knockdown mice (VAChT-KDHET) have a 
40% decrease in VAChT expression but they survive into adulthood with no muscular 
dysfunction but similar cognitive changes to those seen in the VAChT-KDHOM mice 
(Prado et al., 2006).  
VAChT is a 12-transmembrane domain protein with a 75 kDa molecular mass that is 
part of the Major Facilitator Superfamily of transporters (Alfonso et al., 1994; Erikson et 
al., 1994; Vardy et al., 2004). The exact three-dimensional structure of VAChT is not 
known, but a model has been proposed based on the structure of two other members of 
this family: lactose permease and glycerol 3-phosphate (Vardy et al., 2004). The 12 
transmembrane helices are suggested to form two bundles, one composed of helices I-IV 
and the other composed of helices VII-XII (Khare et al., 2010), with both the N- and C-
terminus regions projecting into the cytoplasm. It is helix X that contains Trp331 and 
Asp398 which are the amino acids involved in ACh binding and proton translocation, 
respectively (Fritz et al., 2001; Kim et al., 1999). VAChT has been localized to the 
perinuclear region in the cell bodies of ChAT-positive neurons, as well as to the nerve 
terminals (Roghani et al., 1998). Of the two types of secretory vesicles in the cholinergic 
nerve terminal (synaptic vesicles and large-dense core vesicles, LDCVs), immunogold 
studies indicate that VAChT is found in the synaptic vesicle population (Gilmore et al., 
1996). The C-terminal of VAChT contains a di-leucine motif required for clathrin-
mediated endocytosis, and this is the site of regulation for its trafficking within the 
neuron (Varoqui and Erickson 1998; Barbosa J Jr et al., 2002; Ferreira et al., 2005). The 
amino acid sequence of the C-terminal tail of VAChT reveals a consensus 
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phosphorylation site for PKC, suggesting that post-translational modification of VAChT 
could change ACh storage, and subsequently release (Erickson et al., 1994, Roghani et 
al., 1994). Specifically, Krantz et al. (2000) identified serine 480 as the major 
phosphorylation site in the protein and PKC as the kinase involved. Krantz et al. (2000) 
also demonstrated in stable transfected PC12 cells that a S480E mutation increases 
VAChT expression in LDCVs by diverting VAChT trafficking away from endosomes. 
VAChT utilizes the electrochemical gradient created by V-type proton ATPase 
(Parsons 2000) to bring ACh into the synaptic vesicle by exchanging two luminal protons 
for a cytoplasmic ACh molecule (Nguyen et al., 1998). The impermeability of the 
secretory vesicles provides a large proton-motive force that drives the accumulation of 
ACh inside the vesicle so that the vesicular ACh concentration is 100-fold greater than 
the cytoplasmic concentration (Eiden 1998). However, the electrochemical potential 
created by the ATPase is sufficient to concentrate ACh 3000-fold greater in synaptic 
vesicles than in the cytoplasm, suggesting that there are regulatory mechanisms that 
arrest the vesicular ACh filling (Parsons 2000). Varoqui and Erickson (1996) 
demonstrated that VAChT is a very slow transporter, and that in PC12 cells that 
overexpress human VAChT, the transport of [3H]ACh is saturable, suggesting that 
VAChT is likely the rate-limiting step for ACh release from the nerve terminal.  The 
level of expression of VAChT thus has a great influence on the release of this 
neurotransmitter. Song and colleagues (1997) over-expressed VAChT in xenopus 
neurons and found that it increased the amount of ACh released by the synaptic vesicles. 
As well, they found that the neuron had an increase in the number of miniature EPSPs, 
which suggests that more synaptic vesicles were becoming competent to store and release 
ACh than usual (Song et al. 1997). Synaptic vesicles themselves do not regulate the 
amount of ACh stored within them, but the level of VAChT expression on the vesicle 
dictates the amount of neurotransmitter released (Prado et al., 2002).  
1.5 ACh-Glutamate Co-transmission 
Recent studies have shown that some cholinergic neurons in the brain express a 
vesicular glutamate transporter (VGluT) in addition to VAChT, and thus have the 
potential to release both ACh and glutamate. For example, cholinergic neurons in the 
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striatum co-express VGluT3 (Schafer et al., 2002; Gras et al., 2008; Guzman et al., 
2011). Basal forebrain cholinergic neurons projecting to the amygdala also co-express 
VGluT3 (Nickerson et al., 2006). While the mechanisms of regulation of VAChT are 
unknown, it has been shown that ACh loading into the synaptic vesicles can be 
influenced by the VGluT3 activity through a process called vesicular synergy (Gras et al., 
2008). It has been suggested by Hnasko and collegues (2012) that accumulating the 
negatively charged glutamate inside these cholinergic neurons changes the pH value to 
increase VAChT transport activity.  
 In a number of studies, animal models of cholinergic deficiency have generated 
by using electrolytic or excitotoxic methods, as well as cholinergic immunolesion, to 
ablate cholinergic neurons (Schliebs and Arendt, 2006). These studies often destroy non-
cholinergic neuron in addition to the cholinergic neurons, or they do not fully deplete the 
cholinergic neurons. More importantly, lesions destroy neurons that may be co-releasing 
glutamate and ACh, which prevents researchers from distinguishing the behavioural 
effects of these two neurotransmitters. The use of genetically modified mice with VAChT 
knockouts restricted to a unique brain region provides a means to elucidate the role of 
cholinergic deficiency specifically (Guzman et al., 2011; Martyn et al., 2012; Kolisnyk et 
al., 2013). 
The comparison of striatal VGluT3-KO mice with striatal VAChT-KO mice 
(VAChTD2-Cre-flox/flox mice) highlights the effect of ACh/glutamate co-transmission, and 
also the importance of separating the physiological role of each of these neurotransmitters 
(Guzman et al., 2011). For instance, mice with a lesion of cholinergic neurons in the 
striatum have been found to be hyperactive and more responsive to cocaine than controls 
(Hikida et al., 2001; Kitabatake et al., 2003), so this phenotype was initially attributed to 
the loss of cholinergic signaling from striatal interneurons. Two genetically modified 
mouse lines were created to differentiate the behaviours controlled by the glutamateric 
and cholinergic neurotransmission. VGluT3-KO mice did not have glutamate release 
from the striatal cholinergic interneurons, and behavioural analysis of these VGluT3-KO 
mice revealed that they are also hyperactive and more responsive to cocaine than controls 
(Gras et al., 2008). The VAChTD2-Cre-flox/flox mice do not release acetylcholine from 
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striatal cholinergic interneurons but the behavioural analysis of these mice revealed that 
they are not hyperactive and they do not have altered cocaine-induced behaviour 
(Guzman et al., 2011). This comparison suggests that it was the glutamate release from 
the cholinergic neurons, not the ACh release that was responsible for the phenotype 
observed in the lesion studies. 
2 Pedunculopontine Tegmental Nucleus 
Integrity of the proteins involved in ACh synthesis, storage and release, functioning 
muscarinic and nicotinic receptors and intact neurons are all critical for the functioning of 
the cholinergic system. Dysfunction of the cholinergic system has been implicated in a 
number of diseases, such as Alzheimer’s disease (Prado et al., 2013). The potential role 
of altered cholinergic signaling in neurobiological disease has brought the 
pedunculopontine nucleus (PPN, in humans) or pedunculopontine tegmentum (PPT, in 
rodents) into the scientific spotlight. Significant loss of cholinergic neurons of the PPT 
has been demonstrated in post-mortem studies of patients with Parkinson’s disease (PD) 
and progressive supranuclear palsy (PSP), a Parkinson’s-like syndrome (Jellinger 1988, 
Warren et al., 2005). It has been shown that 40-50% of PPN cholinergic neurons 
degenerate in Parkinson’s patients and over 60% degenerate in patients with PSP 
(Jellinger 1988).  Understanding the behaviours regulated by this cholinergic nucleus is 
fundamental in determining how degeneration in this area leads to the symptoms 
observed in PD and PSP patients.  
2.1 PPT Anatomy 
The PPT is composed of a highly heterogeneous population of neurons that differ by 
their connectivity, behaviours they regulate, and their discharge properties (Martinez-
Gonzalez 2012).  The three major neuron types in the PPT are cholinergic, GABAergic 
and glutamatergic (Martinez-Gonzalez 2012).  Not only are the types of neurons and their 
function heterogeneous, but so is the distribution of these neuronal subtypes across the 
PPT. The pedunculopontine tegmental nucleus has two subdivisions based on the cell 
density and distribution of the Ch-5-group cholinergic neurons: the pars compacta (PPTc) 
and pars dissipates (PPTd) (Papahill et al., 2000). However, these two subdivisions may 
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best be considered anatomically as a two-component structure, with each component 
being responsible for distinct behavioural and psychological functions (Winn 2006).  
Immunolabeling has identified a rostro-caudal distribution of ChAT-labeled 
cholinergic neurons, with more of these neurons in the caudal portion of the PPT 
(Martinez-Gonzalez 2012).  GABAergic neurons are more concentrated in the rostral 
PPT and glutamatergic neurons are more concentrated in the caudal PPT (Martinez-
Gonzalez 2012).  The rostro-caudal distribution of the different neuronal subtypes is 
highlighted by the changes in cytoarchitecture and organization of the cholinergic 
neurons along this axis (Martinez-Gonzalez et al., 2011).  Where there is low GABAergic 
neuron density (caudal PPT) the cholinergic neurons are bipolar-shaped and organized in 
a layer like structure; where GABAergic neuron density is high, the cholinergic neurons 
are round-shaped and in a random distribution (Martinez-Gonzalez et al., 2011). The 
unique distribution of each neuron subtype is related to the distinct connectivity of the 
rostral and caudal portions of the PPT, which suggests that the two regions might be 
functionally distinct. Neurochemically, the rostral and caudal sections of the PPT each 
have distinct and diverging projections that innervate distant structures (Martinez-
Gonzalez et al., 2011). 
In addition to the two shapes of the cholinergic neurons in the PPT, they have also 
been shown to have two types of firing patterns: slow-firing and fast-firing (Martinez-
Gonzalez et al., 2011).  Mena-Segovia et al. (2008) demonstrated that the slow-firing 
neurons correlate to the cortical upstate during slow oscillations and the fast-firing 
neurons correlate to the cortical downstate during slow oscillations. 
Understanding the different roles each neuronal subtype of the PPT plays in 
regulating behaviour is further complicated by the fact immunohistochemistry studies 
revealed that 40% of cholinergic neurons in this region also show glutamate 
immunoreactivity (Lavoie and Parent, 1994), suggesting that these neurons can co-release 
acetylcholine and glutamate.  Immunolabeling studies also suggest that some cholinergic 
neurons of the PPT coexpress GABA markers as well (Wang and Morales, 2009). 
However, when mRNA transcripts of ChAT and glutamic acid decarboxylase (GAD; 
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required for production of GABA) were evaluated using in situ hybridization, they found 
that only 2% of PPT cholinergic neurons expressed GAD mRNA (Wang and Morales, 
2009).  
2.2 PPT Connectivity 
2.2.1 Efferent Connectivity 
A fundamental characteristic of the PPT is the long axons of the cholinergic 
neurons that project to very distant structures and have as many as five or six collaterals 
(Mena-Segovia et al. 2008).  
Numerous tracer experiments have shown that the PPT projects to unique regions 
within the basal ganglia system. The subthalamic nucleus (STN) receives cholinergic, 
GABAergic and glutamatergic input from the caudal PPT in the monkey (Lavoie and 
Parent, 1994; Bevan and Bolam, 1995; Martinez-Gonzalez et al. 2009). The internal 
globus pallidus (GPi) in monkeys receives projections from the rostral PPT, of which 
40% of the neurons are cholinergic (Woolf and Butcher, 1986; Edley and Graybiel, 
1983). The external globus pallidus (GPe) receives only a small input from the PPT 
(Charara and Parent, 1994). The dopaminergic neurons of the substantia nigra (SN) 
receive input from the rostral PPT, specifically the pars compacta region (SNc) (Futami 
et al., 1995; Charara et al., 1996). In monkeys, 25% of these neurons are cholinergic 
(Lavoie and Parent, 1994).  The ventral tegmental area receives significant cholinergic 
input from the caudal PPT in primates (Charara et al., 1996). The thalamus is one of the 
primary output centres of the PPT and it is heavily innervated by cholinergic neurons 
from the caudal PPT in the monkey (Parent et al., 1988, Takakusaki et al., 1996). 
Additionally, the striatum also receives direct projections from the PPT (Nakano et al., 
1990; Dautan et al., 2014). 
Until recently, it was believed that cholinergic interneurons were the only source 
of ACh in the striatum, and that the PPN only influenced the striatum indirectly through 
one of two routes: (1) innervation of midbrain dopaminergic neurons (Bolam et al., 1991) 
leading to increased dopamine release onto the striatum (Blaha and Winn, 1993) and (2) 
through innervation of the intralaminar and midline thalamus (Mena-Segovia et al., 2008) 
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which then project to the striatum (Erro et al., 1999). However, Dautan et al. (2014) used 
a Cre-driven mouse line to express the fluorescent protein YFP in cholinergic neurons 
(immunolabeled for ChAT) to reveal direct cholinergic innervation of both the dorsal 
striatum and nucleus accumbens from the PPT and LDT. These authors showed that the 
rostral PPT innervates the dorsolateral striatum, and the caudal PPT innervates the 
dorsomedial striatum and nucleus accumbens. Additionally, electron microscopy analysis 
of cholinergic synapses revealed that the 74% of synapses from rostral PPN contacted 
dendritic shafts, suggesting they contact striatal interneurons, and 26% made contact with 
the medium spiny neurons.  
Additional areas that have been shown to receive cholinergic inervation from the 
PPT are: the inferior and superior colliculi which receive fibers from the caudal PPT 
(Mena-Sogovia et al., 2008); the basal forebrain (specifically the magnocellular preoptic 
area and the nucleus basalis magnocellualris) which also receives input from the caudal 
PPT (Semba et al., 1988; Losier and Semba, 1993; Mena-Segovia et al., 2008); the 
posterior lateral hypothalamus (Ford et al., 1995) as well as lower brainstem, pons, 
medulla and spinal cord (Martinez-Gonzalez et al., 2009) (Martinez-Gonzalez et al., 
2009). PPT projections to the spinal cord that are thought to be directly involved in 
locomotion are primarily non-cholinergic (Skinner et al., 1990). Several studies have also 
shown that there is collateralization of targets by the same PPT neurons. For instance, 
Takakusakai et al. (1996) demonstrated that one individual cholinergic neuron will 
project to the SN, thalamus as well as caudal regions in the brainstem. The efferent 
connections from the PPT are summarized in Figure 2. 
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Figure 2. Summary of efferent connections of the PPT. GPe = external globus 
pallidus, GPi = internal globus pallidus, VP = ventral pallidus, SNc = substania 
nigra pars compacta, SNr = substantia nigra pars reticulate, VTA = ventral 
tegmental area, rPPT = rostral pedunculopontine tegmental nucleus, cPPT = caudal 
pedunculopontine tegmental nucleus, SC = superior colliculus, IC = inferior 
colliculus.   
2.2.2 PPT Afferent Connectivity 
There is not as detailed information regarding the afferent innervation of the PPT, 
but it is known that there are direct afferents from the cerebral cortex, thalamus, 
hypothalamus, pons, cerebellum, medulla, spinal cord and basal ganglia (Saper and 
Loewy, 1982; Semba and Fibiger, 1992).  
In monkeys, the prefrontal and frontal lobe areas of the cerebral cortex that are 
involved in motor control have direct excitatory projections to the PPT (Matsumura et al., 
2000; Martinez-Gonzalez et al., 2011). As well, tracer studies in primates have shown the 
basal ganglia system sends direct projections to the PPT. The STN directly targets 
neurons in the PPT with an excitatory input (Nauta and Cole, 1978; Martinez-Gonzalez 
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2011) and also indirectly though the SN (Florio et al., 2007). Additionally, the SN pars 
reticulata (SNr) has direct projections to the rostral PPT (Nakamura et al., 1989; Semba 
and Fibiger, 1992; Spann and Grofova, 1991). The enteropeduncular nucleus (rodents) or 
GPi (humans) sends GABAergic projections to the rostral PPT (Morizumi and Hattori, 
1992).  The ventral striatum was shown to project GABA-releasing neurons to the PPT in 
monkeys (Haber et al., 1990).  
The PPT receives afferents from deep cerebellar nuclei (Hazarati and Parent, 
1992) and receives fast sensory input from superior colliculi in the rat tectum (Woolf and 
Butcher, 1986; Semba and Fibiger, 1992).  In tracer studies of the rat brainstem, it has 
been shown that the dorsal raphe neurons innervate the caudal PPT providing a 
serotonergic input (Steininger et al., 1992). The PPT also receives input from the 
laterodorsal tegmental nucleus (LDTg) and the contralateral PPT (Semba and Fibiger, 
1992).  
As a result of these connections, the PPT receives both sensory and motor inputs, 
as summarized in Figure 3.  
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Figure 3. Summary of afferent connections to the PPT. GPe = external globus 
pallidus, GPi = internal globus pallidus, VP = ventral pallidus, SNc = substania 
nigra pars compacta, STN = subthalamic nucleus, SNr = substantia nigra pars 
reticulate, VTA = ventral tegmental area, DR = dorsal raphe, rPPT = rostral 
pedunculopontine tegmental nucleus, cPPT = caudal pedunculopontine tegmental 
nucleus, LDT = laterodorsal tegmentum.   
2.3 PPT Function 
The PPT, with its widespread-projecting neurons and heterogeneous neuronal 
subpopulations, is thought to have a complex role in a number of signaling networks in 
the brain. Many studies have investigated the possible functional role of the PPT, and to 
date, this nucleus is thought to be involved in locomotion and gait, REM sleep/brain state 
transitions, and cognitive functions such as attention and reward learning (Winn et al., 
2011). 
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2.3.1 Locomotion and Gait  
Strong reciprocal connections have been shown between the PPT and structures 
involved in the control of motor performance such as the basal ganglia; specifically, the 
STN, the SN and the GP (Bolam et al., 1991; Winn et al., 1997; Kita and Kita, 2011). 
Recent studies with retrograde and anterograde tracing have identified neuronal circuitry 
that is likely to be responsible for the control of locomotion, posture and muscle tone. 
Rolland et al. (2011) proposed that the SNr-PPT-reticulospinal circuit could control 
posture and axial muscle tone, and the GPi-PPT-reticulospinal circuit could control gait 
and locomotion (Rolland et al., 2011). Hikosaka et al. (2000) expanded on the role of the 
basal ganglia in the control of movements by suggesting that the basal ganglia has two 
kinds of outputs: the thalamocortical network to control volitional movement, and the 
outputs to the PPT to control autonomic movements such as saccades and locomotion.  
Literature confirming the role of the PPT in locomotion is mixed, however. While 
the PPT is considered to be part of the mesencephalic locomotor region, bilateral 
excitotoxic lesions of the whole PPT failed to show any effects on locomotion (Inglis et 
al., 1994) while bilateral lesions of just the anterior PPT causes a reduction of locomotion 
in rats (Alderson et al., 2008). Takakusaki (2008) suggested that the PPT is required for 
the initiation and maintenance of motion, and in primates, lesioning the PPT with high 
frequency stimulation causes akinesia (Nandi et al., 2002).  
Neuropathalogical studies have shown that in humans, 40%-60% of the 
cholinergic neurons in the PPT degenerated in PD and PSP patients, respectively 
(Jellinger 1988; Bohnen and Albin, 2011). This degeneration of PPT cholinergic neurons 
results in cortical and thalamic cholinergic denervation, which is related to gait and 
balance issues in these individuals with PD (Bohnen et al., 2009). The AChE inhibitor 
donepezil reduced the number of falls in patients with PD by 50% (Chung et al., 2010). 
Interestingly, in a rat model of PD (created with 6-hydroxydopamine lesions of the 
medial forebrain), analysis of firing patterns of neurons in the basal ganglia system and 
PPT following lesion revealed that the resulting increased oscillatory activity in the STN 
and SNr is transmitted to the PPT as inhibitory oscillatory output (Aravamuthan et al., 
17 
 
2008). These results emphasize the relationship between the PPT, basal ganglia and 
motor disturbances in PD. 
2.3.2 Cognitive functioning 
In addition to the locomotor and gait abnormalities observed in individuals with 
PD or PSP, the loss of cholinergic PPT neurons in both diseases is also thought to play a 
role in the attentive and cognitive impairments seen in patients (Scarnati and Florio, 
1997).  
2.3.2.1 Arousal and Attention 
Electroencephalography (EEG) has been used to monitor the electrical activity in 
the cortex, and there is a pattern of electrical potentials corresponding to an arousal state 
(McCormick 1989). For instance, during slow-wave sleep there is a synchrony of cortical 
activity, but during wakefulness and alertness there is a desynchronization of the 
electrical activity (McCormick 1989). It is known that the thalamus mediates these brain 
state transitions by coordinating the neuronal changes from a slow firing rate to phasic 
burst firing (Mena-Segovia et al., 2008). The connection between the intralaminar 
thalamic nuclei and the PPT has been associated with arousal and attention (Steriade et 
al., 1988). Electrical stimulation of the PPT results in this desynchronized EEG, which 
supports the role of the PPN in thalamocortical process like arousal (McCormick 1989). 
Kobayashi and Isa (2002) found that increased excitability of thalamic neurons increases 
visual acuity by decreasing the signal-to-noise ratio of the incoming sensory information. 
Behaviourally, this increases alertness and awareness of sensory information from the 
environment.  
The interaction between the PPT and the thalamus is also thought to influence 
attention. Attention involves the ability to detect sensory stimuli, maintain readiness to 
respond to stimuli (sustained attention), discriminate significant from insignificant 
stimulus (selective attention) and to select and perform the appropriate motor response 
(executive control) (Inglis et al., 2000). The 5-choice serial reaction time task (5CSRTT) 
is frequently used to evaluate attentional processes in rodents.  In the 5-CSRTT 
paradigm, animals are required to detect brief flashes of light presented pseudorandomly 
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in one of five locations on a screen and to make a nose-poke response in the correct 
spatial location in order to receive a food reward (Bari et al., 2008). The accuracy of the 
animal’s response to the light stimulis provides an index of attentional capacity (Bari et 
al., 2008). Inglis et al. (2000) lesioned the PPT in mice and evaluated the resulting affects 
on attention using this task. Mice with bilateral PPT lesions showed decreased 
accuracy and a very high percentage of trials on which no response was made 
(omissions) when attentional demands of the task were increased by decreasing the 
stimulus duration. These results suggest that the mice are not vigilant to the stimuli, 
which emphasizes the importance of the integrity of PPT signaling in attentional 
processes.  
2.3.2.2 Working memory 
The PPT-thalamus circuit has been suggested to be involved in working memory. 
Cholinergic innervation to the  anteroventral thalamic nucleus (ATN) were shown to be 
responsible for spatial- and context-dependent memory (Mitchell et al., 2002). 
Additionally, lesions of the ATN in rats led to significant spatial memory deficits in the 
radial maze (Sziklas and Petrides 1999). The ATN receives one of the highest numbers of 
cholinergic terminals in all of the thalamus from the PPT (Van Groen and Wyss, 1993), 
supporting the inclusion of PPT cholinergic signaling in the regulation of spatial memory.  
2.3.2.3 Reinforcement learning  
Stimulus-response and action-outcome associations are thought to be mediated by 
the basal ganglia, specifically due to the input from tonically active neurons in the 
striatum that respond to salient sensory events during behavioural conditioning (Schulz 
and Reynolds, 2012). These tonically-active neurons (TANs) are cholinergic interneurons 
that exhibit a tonic spike discharge (Schulz et al., 2011). Lapper and Bolam (1992) 
showed that most of the excitatory inputs to the TANs come from the intralaminar nuclei 
of the thalamus, which drives the spiking of the TANs. Electrical stimulation of the 
thalamus evoked the spiking of the striatal TANs (Schulz et al., 2011). Schulz and 
Reynolds (2013) proposed that regulation of TANs signaling is due to a glutamatergic 
input from the thalamus that is triggered by a an early sensory structure, such as the SC or 
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the PPT, to ensure that the dopamine burst is uninhibited and delivers a strong 
reinforcement signal for the event. In response to salient stimuli, and also to cues that 
predict magnitude of reward outcome, PPT neurons become phasically active (Pan and 
Hyland, 2005) (Okada et al., 2009), so it is been suggested that PPT outputs, or its 
projections to the SC, could be modulating thalamic control of striatal interneurons.  
Condé et al. (1992) proposed a learning process model involving the PPT input to 
the midbrain dopaminergic neurons as a carrier of reinforcement information. Stimulation 
of the PPT results in excitation of the dopaminergic neurons of the SNc and the VTA 
(Lacey et al., 1990), which is essential for burst firing in dopaminergic neurons. 
Acetycholine acts on nicotinic receptors to depolarize the dopaminergic neurons and alter 
their firing rate (Calbresi et al., 1989; Lacey et al., 1990).  Rats with lesions in the 
posterior PPT (pPPT) have been shown to perform worse than those with anterior PPT 
lesions (aPPT) or sham lesion mice in a level-release paradigm, as they were slower to 
learn the association between the lever release and the reward (Wilson et al., 2009), 
suggesting the PPT-ventral striatal circuitry connection is key for reward-reinforcement 
learning. Lesions of the PPT also blocked the reward effects of morphine, amphetamine 
or food as measured in the conditioned place preference test (Olmstead and Franklin 
1993, 1994). Studies suggest that the PPT is involved in the process of forming as well as 
strengthening or maintaining rewarded behaviours through the regulation of dopamine-
releasing neurons in the SNc and the VTA (Allen and Winn, 1995).  
Recent research using a saccade task in monkeys has also focused on the interplay 
between the PPT-Dorsal raphe-Basal ganglia systems and their combined effect on 
reinforcement learning (Okada et al., 2011).  These studies suggest that the PPT neurons 
may be involved in reward prediction. They proposed that the reward prediction 
information from the PPT and the actual information about the value of the reward from 
the dorsal raphe are integrated to evaluate the errors in reward prediction and signal to 
midbrain dopaminergic neurons to reinforce the learned behaviours that elicit the reward, 
as summarized in Figure 4.   
20 
 
 
Figure 4. Summary of PPT-Dorsal raphe-Basal ganglia reinforcement learning 
circuitry. Nac = nucleus accumbens, GPe = external globus pallidus, GPi = internal 
globus pallidus, VP = ventral pallidus, SNc = substania nigra pars compacta, SNr = 
substantia nigra pars reticulate, VTA = ventral tegmental area, PPT = 
pedunculopontine tegmental nucleus, Ser = serotonin, DA = dopamine.  Adapted 
from Okada et al., 2011.  
2.3.3 Sleep 
The PPT is thought to be part of the reticular activating system that drives global 
brain-state transitions (Ros et al., 2010). This link between cortical brain state and the 
PPT is supported by studies that show increases in firing rate of cholinergic neurons 
during spontaneous and sensory-induced brain state transitions from slow-wave activity 
to activated brain states (fast-frequency, low amplitude; typical of wakefulness, arousal 
or REM sleep (Mena-Segovia et al., 2008).  
It has been postulated for many years that the PPT is involved in the control of 
rapid eye movement (REM) sleep (Garcia-Rill 1991). This theory has been supported by 
the comorbidity of sleep disturbances and the later onset of motor and cognitive decline 
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seen in progressive neurodegenerative disorders such as Parkinson’s disease and 
progressive supranuclear palsy (PSP), where there is selective loss of cholinergic neurons 
in the PPT as well as other neuronal populations (Raggi and Ferri, 2010). Additionally, 
this is supported by anatomical studies of the PPT. The PPT projects directly to the 
thalamocortical system and also to the basal forebrain, both of which cause cortical 
activation during waking and REM sleep (Petrovic et al., 2013).  
To clarify the role of the PPT in REM sleep regulation, Petrovic et al. (2013) 
lesioned the PPT bilaterally in rats and evaluated the effect on sleep-wake states using 
EEG. These studies showed that the lesions did not affect the sleep/wake cycle, but it did 
alter the structure of the sleep-wake transitions. There was an increase in the number of 
Wake/REM and REM/Wake transitions that was sustained for 5 weeks after the 
surgeries. The EEG showed that the lesions increased the Wake theta amplitude and the 
REM beta amplitude, demonstrating increased cortical activation (Petrovic et al., 2013).  
Robust firing of midbrain dopaminergic neurons have been observed during REM 
sleep, concurrent with ACh and glutamate release from the PPT onto nigrostriatal 
dopaminergic neurons (Dahan et al., 2009). It has been proposed by Lima (2012) that the 
release of glutamate and ACh from the PPT onto the substantia nigra and VTA causes a 
dopaminergic release onto the reticular formation causing the activation of REM sleep. 
Degeneration of cholinergic signaling from the PPT disrupts this pathway and leads to 
sleep pathologies, which is often comorbid with PD motor symptoms (Lima 2012).   
3 Rationale and Hypothesis 
The physiological role of ACh released from cholinergic neurons from the 
pedunculopontine tegmental nucleus (PPT) is still poorly understood. Here, we generated 
mice with VAChT deletion selectively from PPT cholinergic neurons to investigate how 
ACh signaling from this nucleus contributes to different brain functions.  This provides 
the opportunity to evaluate the consequences of decreased cholinergic signaling from the 
PPT in vivo. 
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Based on the efferent connectivity from the PPT, our hypothesis is that decreased 
cholinergic signaling from the PPT will affect specific behavioural outputs such as gait, 
motor control and sleep.  
Improving our understanding of cholinergic signaling from the PPT and how it 
relates to behavioural abnormalities may lead to the development of novel treatments for 
the symptoms of neurological diseases such as PD and PSP. 
4 Methods 
4.1 Ethics Statement 
All experiments were carried out following guideline set by the Canadian Council of 
Animal Care (CCAC), with the protocol approved by the University of Western Ontario 
Institutional Animal Care and Use Committee (protocol 2008-127). Only male mice were 
used in the behavioural studies. Mice were housed two to four per cage in a room with a 
14-hour light/10-hour dark cycle, and provided access to food and water ad libitum. 
4.2 Animals  
Pedunculopontine tegmental nucleus-specific VAChT knockout mice (VAChTEn1-Cre-
flox/flox) were generated using a Cre recombinase/LoxP system. In short, VAChTflox/flox 
mice (Martins-Silva et al., 2011; mixed C57BL/6J x 129/SvEv background, backcrossed 
to C57BL/6J for five generations) were crossed with the En1-Cre mice (Jackson 
Laboratories, stock no. 007916; Kimmel et al., 2000; mixed 129S1/SvImJ background, 
backcrossed to C57BL/6J in our laboratory for at least two generations). We then 
intercrossed VAChTEn1-Cre-flox/wt mice to obtain VAChTEn1-Cre-flox/flox.  Control mice used 
in our experiments are littermates VAChTflox/flox. Only male VAChTEn1-Cre-flox/flox mice 
greater than three months of age were used in these experiments with male VAChTflox/flox 
age-matched controls.  
Rosa26-tdTomato mice (B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, Jackson 
Laboratories, stock no. 007914; Madisen et al., 2010) have a loxP-flanked STOP cassette 
to prevent the transcription of the downstream red fluorescent protein variant, tdTomato. 
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These mice were bred to mice expressing Cre recombinase under the control of the En1 
promoter (En1-Cre mice). The offspring generated as a result of this breeding express 
dTomato in all Cre-expressing tissues. These mice were analyzed by 
immunohistochemistry to determine the brain regions where En1-Cre is expressed in 
cholinergic neurons. 
4.3 Immunohistochemisty and Western Blots 
For the immunofluorescence experiments, mice were anesthetized with ketamine 
(100mg/kg)-xylene (20 mg/kg) then perfused transcardially with 4% paraformaldehyde 
(v/v) in phospho-buffered saline (PBS) (pH 7.4). Brains from VAChTEn1-Cre-flox/flox mice 
and VAChTflox/flox mice were removed and incubated in 4% paraformaldehyde in PBS 
overnight at 4°C. Brains were sectioned in the sagittal plane using a vibratome (40 µm 
thick) and transferred into a six well plate with each well containing PBS. Slices were 
place one per well in a clockwise manner. All slices within only one well were selected 
for immunohistological analysis. These selected free-floating slices were then washed 
with Tris-buffered saline (TBS) (pH 7.6) 3 times for 15 minutes then blocked and 
permeabilized by incubation for 1 h at room temperature in TBS with 0.2% Triton X-100, 
3% bovine serum albumin (w/v), and 5% normal horse serum. Sections were then 
incubated for 48 hours at 4°C with mouse anti-CHT1 (high-affinity choline transporter 1) 
(catalog #ab5966; Millipore) at a 1:500 dilution in 1:1 TBS and blocking solution. Slices 
were washed 3 times for 15 min in TBS with 0.1% Tween20 (TBST), brain slices were 
incubated with the seconday antibody (an Alexa488 dye-conjugated rabbit anti-mouse 
IgG; catalog #a6662; Abcam) in 1:1 TBS and blocking buffer overnight at 4°C. Sections 
were washed five times for 10 minutes in TBS then mounted on slides with 
Immunomount (Thermo Scientific, Massachusetts, USA) and visualized using Leica-SP5 
laser-scanning microscope using an argon laser and HeNe1 laser. Images were taken 
using Leica SP5 fluorescence microscope with a 40x oil immersion objective (1.25 NA).  
For each mouse, one image of each brain region was quantified and the percent 
colocalization of tdTomato and CHT1-labelled neurons was quantified. This value was 
obtained for four mice from each genotype and averaged.  
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For Western blot analysis, fresh brain tissue was used from both VAChTEn1-Cre-flox/flox 
mice and VAChTflox/flox control mice. To prepare extracts, tissues were homogenized in 
buffer containing 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100 and protease inhibitor cocktail. Extracts remained at 4oC for 20 minutes then 
centrifuged (10,000 x g x 20 min). Protein concentration of the supernatant was 
determined using the Bradford method. 50 µl of protein was loaded into precast 12% gels 
(Lonza; Basel, Switzerland) and run for 90 minutes at 120 volts. Protein was then 
transferred to PVDF membrane using Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad; 
Hercules, CA). For immunoblotting, membranes were washed with TBS with 0.05% 
Tween20 (TBST) for 10 minutes then incubated with blocking solution (5% milk in 
TBST) for one hour. Membranes were then incubated in primary antibody at 4oC 
overnight diluted in blocking solution. Antibodies were rabbit anti-VAChT (catalog 
#139103; Synaptic Systems) at a 1:3000 dilution and mouse anti-Synaptophysin (catalog 
#S5768; Sigma-Aldrich) at a 1:500 dilution. After, membranes were washed with TBST 
three times for fifteen minutes each. Membranes were developed using Amersham ECL 
Plus reagent kit (GE Life Sciences; Pittsburgh, PA). Non-saturated autoradiographs were 
analyzed with ImageJ.  
4.4 Grip Strength and Wire Hang 
A Grip Strength Meter from Columbus Instruments (Columbus, OH) was used to 
measure forelimb grip strength (Prado et al., 2006; Deacon, 2013). Mice grasped the 
smooth pull bar of the apparatus with forelimbs only and then were pulled backwards by 
the tail horizontally. The force applied to the bar immediately before grasp was released 
was recorded. 3 measurements were recorded per animal and averaged. The inter-trial 
interval for each mouse was 30 seconds, during which the mouse was returned to its 
home cage.  
For the Wire Hang test (Prado et al., 2006; Deacon, 2013), each mouse was placed on 
a metal wire-grid, which was slowly inverted and suspended 40 cm above a piece of 
foam. The time for each mouse to fall from the wire was recorded with a 60s cut-off. The 
inter-trial interval for each mouse was 30 seconds, during which the mouse was returned 
to its home cage. 
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4.5 Open Field Locomotion 
To measure spontaneous locomotor activity in new environments (Pierce and Kalivas, 
2007; de Castro et al., 2009), mice were placed in an open field arena (20 cm x 20 cm 
platform with 30 cm high walls) and movement in the arena was recorded by VersaMax 
Animal Monitoring System from AccuScan Instruments Inc. (Columbus, OH). Mice were 
placed in the centre of the apparatus and allowed to freely explore the novel environment 
for 120 minutes in the light followed by 120 minutes in the dark. VersaMax converts 
infrared beam breaks into movement (cm) per 5-minute interval. For intersession 
habituation, mice spent 120 min in the same open field apparatus for three consecutive 
days. Measurements of total activity were obtained.  
4.6 Rotarod 
For the rotarod task (Prado et al., 2006; de Castro et al., 2009), mice were placed on 
the accelerating rotarod apparatus (San Diego Instruments; San Diego, CA) for ten trials 
with an inter-trial time of 10 minutes during which mice were placed in their home cage. 
On the second day the animals underwent four more trials with the same conditions from 
the previous day. Animals were allowed to acclimate to the rod for 5 seconds before the 
trial started. For the first 100 seconds the revolutions per minute (RPM) was 5, then 15 
RPM for the subsequent 100 seconds, then 25 RPM for the next 100 seconds and finally 
35 RPM for the final 100 seconds. The software records latency to fall. Rod was cleaned 
with 70% ethanol between trials.  
4.7 CatWalk Gait Analysis 
The CatWalk XT system by Noldus (Leesburg, VA) was used to assess the gait of the 
animals (Koopmans et al., 2005).  The apparatus is made of a 1.3 m long glass plate with 
dim fluorescent light beamed into the glass from the side. The paw in contact with the 
glass was recorded by a video camera underneath the walkway. Mice were allowed free 
exploration of the walkway for 1 min. Three correct runs (the mouse crossed the 
walkway with no interruption or hesitation) for each mouse was recorded. Runs were 
analyzed using the Noldus software. Stride length is defined as the distance between two 
successive prints of the same paw.  
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4.8 Metabolic cages 
Oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory 
exchange ratio (RER), food and water intake, and physical activity were simultaneously 
measured using the Comprehensive Lab Animal Monitoring System (CLAMS) interfaced 
with Oxymax software (Columbus Instruments; Columbus, OH) (Guzman et al., 2013). 
Mice were housed individually in the metabolic chambers maintained at 24 ± 1°C. Mice 
had free access to powdered standard rodent chow and water. Mice had a 24 h habituation 
period, after which measurements were taken every 10 min for 24 h (12-h light/ 12-h 
dark). VO2, CO2, RER, food and water intake, ambulatory activity, and sleep (periods of 
inactivity) measurements were obtained using the Opto-M3 Activity Monitor and 
Oxymax software algorithms (Columbus Instruments; Columbus, OH). 
4.9 Forced Swimming Test and Tail Suspension Test 
The forced swimming test (FST) and tail suspension test (TST) were used to measure 
depressive-like behaviour (Martyn et al., 2012). For FST, mice were placed in the testing 
room and allowed to habituate for one hour. Mice were placed in a 2 L beaker with 1.8L 
of 25-27oC water for 6 min. A video monitor was placed above the beaker and using 
ANYmaze software (Stoelting Co., IL) the time spent immobile and distance swam were 
calculated. Only data taken from 2-6 minutes were analyzed. Water was changed every 2-
3 mice.  
For the TST, mice were suspended from a bar 30 cm above a table by their tail, using 
masking tape placed 1.5 inches from the base of the tail, for 6 min (Martyn et al., 2012). 
Sessions were recorded and immobility time and immobility episodes were quantified 
using ANY-Maze software (Stoelting Co., IL).  
4.10 Elevated Plus Maze 
The elevated plus maze is used to investigate murine anxiety (Martins-Silva et al., 
2011). The elevated plus maze is a plus-shaped platform with two open arms and two 
arms with dark plastic walls. Mice were placed in the centre facing the open arm opposite 
the experimenter. Mice were allowed to explore the maze for 5 minutes then they were 
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returned to their home cage. A video monitor was placed above the maze and total 
amount of time spent in the open or closed arms of the maze, as well as total distance 
travelled, was calculated with the Any-maze software (Stoelting Co., IL).  Mice were 
considered to be completely within an arm of the maze when its centre of gravity was in 
that section. All parts were cleaned between animals, first with soap and water followed 
by 70% ethanol.  
4.11 Light/Dark Place Preference Test  
The light/dark place preference test is used to evaluate anxiety-like behaviour 
(Martyn et al., 2012). A black plexiglass insert that is exactly half the area of the open 
field arena (20 cm x 20 cm platform with 30 cm high walls) is placed in the arena. The 
black insert has a small opening in the front to allow the mouse to move freely between 
the open half of the arena or the dark covered half inside the insert. The test is done with 
the mice 30 min into their wake cycle (19:30 h) in a bright room. Mice are placed in the 
centre of the arena and ambulatory activity in a 10 min session is recorded using the 
VersaMax Animal Activity Monitoring System (AccuScan Instruments, Inc.; Columbus, 
OH). All parts were cleaned between animals, first with soap and water followed by 70% 
ethanol.  
4.12 Marble Burying Task  
The marble burying task considered presently to be a measure of repetitive, 
compulsive-like behaviours in mice, although it is still commonly used as a measure of 
anxiety-like behaviour in rodents (Angoa-Perez et al., 2013; Thomas et al. 2009).  20 
glass marbles are arranged evenly on the surface of clean cage partitioned in half with 
bedding that is 2 inches deep. The number of marbles buried in a 15 minute session is 
counted. A marble must be 2/3 covered in bedding to be considered buried.  
4.13 Morris Water Maze  
Spatial memory was assessed using the spatial version of the Morris water maze 
(MWM) (Vorhees and Williams, 2006; Martyn et al., 2012; Kolisnyk et al., 2013). 
External cues were placed around a circular tank, 120 cm in diameter, filled with water at 
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a temperature of 25°C. A circular, clear escape platform, 10 cm in diameter, was placed 
0.5 cm below the surface, such that it was hidden underneath the waterline but still 
mountable. The tank was conceptually divided into four quadrants. Testing was done on 
five consecutive days. On the first four days, the platform was kept in a constant position 
for each mouse. The mouse underwent four trials on each day, starting once at the 
dividing line between each quadrant facing the edge of the tank. 90 s were given for the 
mouse to reach the platform, with its path analyzed using a video monitor placed over the 
tank and ANY-maze software (Stoelting Co., IL). If task was not completed in 90 s, the 
mouse was guided to the platform. The inter-trial interval was 15 minutes. On the fifth 
day, one trial was done for each mouse with the platform removed from the tank. The 
mouse was placed directly opposite of the where the platform used to be, and was given 
60 s swim around the tank. Time spent in the target quadrant was measured using ANY-
maze software (Stoelting Co., IL). 
The cued version of the MWM was performed to assess goal-directed behaviour 
(Rossato et al., 2006). For this variation, the platform was at water level and visible with 
a plastic block cue placed on it, and spatial cues were removed from the room. Mice were 
tested over two days with novel platform and starting location combinations. Mice 
underwent 8 consecutive training trials with a 30 s inter-trial interval on day 1. After 24 h 
the mice are probed for their retention of the trials but undergoing 2 cued trials, this time 
starting from a position that was not used during training. 
4.14 Spontaneous Alternations Y-Maze Task  
Working memory is evaluated using the spontaneous alternations Y-maze task 
(Hughes 2004). Test was performed using a symmetrical Y-shaped maze (30 cm long by 
6 cm wide by 20 cm high) following a protocol previously described (de Castro et al., 
2009; Kolisnyk et al., 2013). Mice were placed at the end of one arm and allowed to 
freely explore the maze for 8 min. A spontaneous alternation occurred when the mouse 
visited all three arms of the maze in sequence without revisiting a previous arm. All 
sessions were recorded and the order and number of arm entries were measured by Any-
maze software (Stoelting Co., IL). The effect was calculated as percentage alternation 
according to the formula: [total alternation/(total arms entered - 2)] x 100. Therefore, the 
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following hypothetical sequence of arms entered by a mouse: A,C,A,B,C,A,C,B,A,C 
would yield an alternation score of 75% ([6 alternations/(10-2) arms entered] x 100). A 
score of 50% means random selection of goals arms. Animals statistically reach more 
than 50% alternation, indicating no random arms selection. By this criterion, we would 
see 100% alternation score only if the animal had run consistently clockwise or 
anticlockwise.  
4.15 5-Choice Serial Reaction Time Task  
4.15.1 Pre-training Phase 
The five-choice serial reaction time task (5-CSRTT) is used to determine attention 
in mice (Robbins 2002; Romberg et al., 2011). Mice were trained in the 5-CSRTT in 
automated Bussey-Saksida Mouse Touch Screen Systems model 81426 (Campden 
Instruments Limited; Lafayette, IN). Schedules were designed and data were collected 
using the ABET II Touch software v.2.15 (Lafayette Instruments; Lafayette, IN).  
Mice first were gradually food restricted and reduced to 85% of their normal 
weight before undergoing a pre-training program that was previously described by 
Kolisnyk et al. (2013) that involved habituating the mouse to the testing chamber for 15 
minutes. The following day, the mouse spent 20 min in the chamber, during which the 
reward tray was illuminated and primed with strawberry milkshake (Saputo Dairy 
Products). Whenever the mouse went to the reward tray, it received the reward paired 
with a tone. The mouse repeated this process for two more days, each with 40 min 
duration.   
In the next pre-training phase, the mice learn to pair the reward with a stimulus (a 
flash of light in one of the 5 windows) on the touchscreen. The stimulus appeared at 
random and remained for 30 s, after which it was removed and a reward paired with a 
tone was given (one trial). Once the mouse collected the reward another trial was 
initiated. This phase was continued until the mouse successfully completed 30 trials 
within a 60 min session.  
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The third phase of pre-training involved teaching the mouse to touch the stimulus 
on the screen. If the mouse touched the stimulus on the screen it received the reward 
paired with the tone. If the mouse touched the screen in where there was no stimulus 
there was no response. This phase was repeated until the mouse consistently completed 
30 trials in a 60 min session.  
Phase 4 was the same as phase 3, which the difference that the mouse had to nose 
poke the reward tray to initiate the trial. This phase was repeated until the mouse 
completed 30 trials in a 60 min session.  
In the final pre-training phase (phase 5), the mice underwent the same procedure 
as in phase 4, but if the mouse touched one of the 5 screens that did not display the 
stimulus (an incorrect screen), it received a 5 s timeout, which was indicated by the 
chamber light turning on during this time. Mice must perform this phase with a minimum 
of 80% accuracy (at least 23 correct responses within 30 trials) within the 60 min session. 
This level of accuracy must be sustained for 2 consecutive days in order for the mouse to 
progress to 5-CSRTT training phase.   
4.15.2 5-CSRTT Training Phase 
In this phase, mice learn to respond to flashes of light pseudo-randomly displayed 
in one of the 5 locations on the touchscreen. The mouse nose pokes the reward dispenser 
to initiate the trial. There is a variable 5-10 s delay period during which the mice must 
attend to the screen, after which the light stimulus appeared on the touch screen. There 
was a 5 s period after the stimulus presentation where the mouse could still respond to the 
location (holding period). If the mouse touched the screen during the delay period, the 
response was recorded as premature and the mouse was punished with a 10 s timeout. A 
response to the stimulus window during stimulus presentation or during the holding 
period was recorded as a correct response. Responses to any other window were recorded 
as incorrect. Correct response was rewarded with the milkshake and tone pairing and an 
incorrect response was punished with a 10 s timeout. Failure to make any response was 
recorded as an omission and the mouse was punished with a 10 s timeout. Perseverative 
responses to the screen after either a premature, correct, or incorrect choice was also 
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recorded. Each session lasted until 50 trials were completed to a maximum duration of 1 
h.  Once the mice reached the criterion at 4 s stimulus duration of a minimum of 30 trials, 
80% accuracy, and 20% omissions for 3 consecutive days, the stimulus duration was 
reduced to 2 s. After mice reached this same criterion for the 2s stimulus duration, the 
mice were tested 2 more days, and the average of those measures was recorded as their 
baseline performance.  
4.15.3 Probe trial 
After the baseline measures had been recorded, the mice were probed for 
attentional deficits in the following probe trial schedule: 2 d at 1.5 s stimulus duration, 2 
d at 1.0 s stimulus duration, 2 d at 0.8s stimulus duration and finally 2 d at 0.6 s stimulus 
duration (Kolisnyk et al., 2013). The order of these probe trial sessions were semi-
randomized using a Latin square method.  
4.15.4 5-CSRTT measurements 
On all 5-CSRTT sessions, accuracy was defined as: [(number of correct 
responses)/(total number of correct and incorrect responses)]. Rate of omissions was 
defined as: [(number of omitted responses)/(total number of responses)]. Response 
latency was defined as the duration of time between the initiation of the trial and the first 
touch of the correct stimulus. Reward collection latency was the duration of time between 
the mouse touching correct stimulus and then returning to the reward tray. A premature 
response was counted when the mouse touched any one of the 5 windows before the 
stimulus onset. A perseverative response was any identical response that occurred after 
either a correct, incorrect, or premature response. (Kolisnyk et al., 2013) 
4.16 Statistical analysis 
Data are expressed as mean ± SEM. Prism 5 and SigmaStat 3.5 software was used for 
statistical analysis. Comparison between two experimental groups was made by Student's 
t test. When several experimental groups or treatments were analyzed, two-way ANOVA 
or two-way ANOVA with repeated measures was used as required. When appropriate, a 
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Bonferroni post hoc comparison test was used. In all comparisons, p < 0.05 was 
considered statistically significant. 
 
33 
 
Chapter 2  
5 Results 
5.1 Immunohistochemistry and Western blot analysis of 
VAChTEn1-Cre-flox/flox mice 
In order to selectively eliminate VAChT in the PPT, VAChTEn1-Cre-flox/flox mice were 
generated using a Cre-loxP system under the control of the regulatory elements 
(homeobox transcription factor 1) encoded by the En1 gene (Kimmel et al., 2000). The 
En1 gene was selected to drive Cre recombinase expression because its expression is 
restricted to the mes/r1 (Kimmel et al., 2000). Previous studies using the En1-Cre 
driverline have found Cre activity in cholinergic neurons of the rostral brainstem 
(including the PPT) but no activity in the more caudal motor neurons in the brainstem 
(Machold 2013).  To test whether Cre was expressed in PPT cholinergic neurons, a 
reporter mouse line was used to reveal the location of En1-cre expression. The reporter 
line used was the Rosa-26-tdTomato mice, in which the Rosa26 locus expresses 
tdTomato once Cre-mediated recombination has occurred.  En1-Cre mice were crossed 
Rosa-26-tdTomato mice and immunofluorescence analysis of En1-Cre:Rosa-26-
tdTomato mice brain slices used to investigate location of Cre expression driven by the 
En1 promoter. The number of neurons revealing colocalization between tdTomato- (red) 
and CHT1-labelled neurons (green) was divided by the total number of cholinergic 
neurons in the PPT  (shown in Table 1) to give a percentage of colocalization for each 
animal. Colocalization (Fig. 6a) was observed on average in 40% of cholinergic neurons 
in the PPT and in 10% of cholinergic neurons in the Mo5 motor nuclei, but no 
colocalization was observed in the 7N motor nuclei, the striatum, and the cortex (Fig. 5; 
Table 1). Sagittal brain slices were selected to reflect the cholinergic nuclei at 
approximately the same lateral position in each animal. It should be noted that the most 
medial slice of the PPT did not have any colocalization between td-Tomato- and CHT1-
labelled neurons, so the percent colocalization may not be consistent throughout the 
entirety of the PPT. We subsequently intercrossed En1-Cre mice with VAChTflox/flox mice 
to generate mice with a selective elimination of VAChT in the PPT.  
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Table 1. Summary of the number of YFP-labeled neurons colocalizing with CHT1-
labeled cholinergic neurons in the immunohistological analysis of the En1-Cre:Rosa-
26-tdTomato mouse line. Values are expressed as the number of YFP- and CHT1-
colabelled neurons out of total number of CHT1-labelled neurons in the image 
obtained for that brain region in each mouse.  
 
Mouse PPT Mo5 7n Striatum Basal 
Forebrain 
1 22/45 9/57 0/48 0/33 0/33 
2 14/54 11/89 0/46 0/29 0/16 
3 3/12 4/84 0/78 0/38 0/29 
4 4/6 5/82 0/72 0/42 0/21 
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Figure 5. En1 promotor drives the expression pattern of Cre Recombinase in 
pedunculopontine tegmental nucleus cholinergic neurons. (a) Sections from reporter 
mouse line, En1-Cre:Rosa-26-tdTomato mice immunostained for CHT1 (green) and 
tdTomato (red). (b) summary of the average percent colocalization observed for 
each brain region; n = 4.  
To indirectly assess the degree of Cre-mediated recombination, Western blot analysis 
of VAChTEn1-Cre-flox/flox mice was performed to evaluate VAChT protein expression. In the 
brainstem, there was 50% decrease in VAChT protein levels (t(6) = 5.123, p = 0.0018; 
Fig. 6a). In the thalamus, the primary output centre of the PPT, there was 90% decrease 
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in VAChT protein levels (t(6) = 3.369, p = 0.0151; Fig. 6b), suggesting that most of the 
Cre-targeted neurons project to this brain area. The hippocampal blot shows a trend that 
suggests the VAChTEn1-Cre-flox/flox mice have twice as much VAChT as controls, however 
this increase is not significant (t(6) = 2.434, p = 0.0509; Fig. 6d). VAChT protein levels 
in the striatum (t(6) = 1.524, p = 0.1785; Fig. 6c) and the cortex (t(6) = 1.273, p = 0.2503; 
Fig 6e) were not significantly affected.  
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Figure 6. VAChT protein expression. Western blot analysis shows VAChT 
knockdown in (a) the brainstem, and (b) the thalamus. VAChT protein levels are 
not significantly changed in (c) the striatum, (d) the hippocampus and (e) the cortex; 
n = 4. Data analyzed using Student’s t-test; *, p < 0.05, **, p < 0.01.  
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5.2 Behavioral analysis of En1-Cre mice 
To test whether the presence of Cre recombinase under the control of the En1 
promotor did not affect the behavioural phenotypes in the genetically modified mice, we 
compared the behaviours of wildtype (WT) mice with En1-Cre mice in a number of 
tasks.  
First, we evaluated locomotor activity of these En1-Cre animals using automated 
locomotor boxes to evaluate spontaneous locomotor activity in a novel environment (Fig. 
7) and habituation. En1-Cre mice were not different from wild-type controls in their 
short-term habituation to the novel locomotor boxes  (F(1,17) = 0.15, p = 0.748) (Fig. 7a) 
or in their total distance covered over the three days of testing (F(1,17) = 0.17, p = 
0.6859) (Fig. 7b).  
 
Figure 7. En1-Cre mice have normal spontaneous locomotor activity. (a) short-term 
habituation in locomotor boxes over two hours on day 1. (b) long-term habituation 
over three days, shown by total distanced travelled during each day. Data expressed 
as mean ± SEM and analyzed using repeated measures two-way ANOVA. WT n = 
13, En1-Cre  n = 9. 
We also evaluated locomotor activity in a  “familiar” environment during their 
wake (dark) and sleep (light) cycles (Fig. 8).   No difference between controls and En1-
Cre mice was observed in the distance travelled during the light and the dark phase 
(F(1,21) = 0.24, p = 0.6322) (Fig. 8).   
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Figure 8. En1-Cre mice have normal spontanous locomotor activity during their 
sleep and wake cycles. Data expressed as mean ± SEM and analyzed using a 
repeated measures two-way ANOVA. WT n = 13, En1-cre n = 10.  
We then used the grip strength test (Fig. 9) as well as the rotarod test to evaluate 
neuromuscular functioning (Fig. 10). In the grip strength test, there was no significant 
difference between the force applied to the grip strength apparatus by the forelimbs (t(21) 
= 1.330, p = 0.1979) (Fig. 9a) or by the hindlimbs (t(21) = 0.5721, p = 0.5733) (Fig. 9b).  
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Figure 9. En1-Cre mice have no physical abnormalities in the grip strength. (a) 
Forelimb grip strength and (b) hindlimb grip strength. Data expressed as mean ± 
SEM and analyzed using a Student’s t-test. WT n = 13, En1-cre n = 10. 
During the rotarod task En1-Cre mice did not significantly differ from their 
controls in their latency to fall off the rod (F(1,21) = 2.37, p = 0.1383) (Fig. 10a) or their 
distance travelled during the task (F(1,21) = 2.27, p = 0.1468) (Fig. 10b). Together, these 
data suggest that the presence of Cre recombinase did not alter the neuromuscular 
functioning of the En1-Cre animals.  
 
Figure 10. En1-Cre mice have normal neuromusclar functioning in the rotarod task. 
(a) Latency to fall of the rotating rod and (b) distance travelled on during the trial. 
Data expressed as mean ± SEM and analyzed using a repeated measures two-way 
ANOVA. WT n = 13, En1-cre n = 10. 
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Taken together, these data indicate that the En1-Cre mice are physically similar to 
control WT mice. We next tested the mice for the presence of psychiatric-like phenotypes 
such as depressive-like behaviour and anxiety-like behaviour. To look for the presence of 
psychiatric-like phenotypes in these animals, we used the forced swim test, the tail 
suspension test (Figure 11), and the elevated plus maze (Figure 12).  
In the forced swimming test, the En1-Cre mice did not significantly differ from 
WT mice in time spent immobile during the final four minutes of the test (t(12) = 0.8330, 
p = 0.4211; Fig. 11a) or in their total distance swam during the test (t(19) = 0.3285, p = 
0.7461; Fig. 11b). This was supported by the results from the tail suspension test, in 
which the En1-Cre mice again were not different from controls in the total time spent 
immobile during the test (t(19) = 0.1814, p = 0.8579; Fig. 11c) or in the number of 
immobility episodes (t(18) = 1.011, p = 0.3254; Fig. 11d). Thus, the presence of Cre 
recombinase under the control of the En1 promoter does not appear to cause a depressive-
like phenotype in these animals. 
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Figure 11. En1-Cre mice do not have a depressive-like phenotype in the forced 
swimming test or the tail suspension test. (a) Time spent immobile and (b) distance 
swam during the forced swimming test. (c) Time spent immobile and (d) number of 
immobility episodes in the tail suspension test.  Data expressed as mean ± SEM and 
analyzed using a Student’s t-test. WT n = 13, En1-cre n = 10. 
 The elevated plus maze was used to evaluate anxiety-like behaviour. En1-cre 
mice spent the same percentage of time on the closed and opened arms of the maze and in 
the centre of the maze as the WT controls (F(1,63) = 0.001, p = 0.9932; Fig. 12a). 
Additionally, the En1-Cre mice made the same number of entries into the open arms of 
the maze as the WT mice (t(20) = 0.7555, p = 0.4587; Fig. 12b). This suggests that the 
En1-Cre mice do not demonstrate anxiety-like behaviour.  
WT En1-Cre
0
100
200
300
Im
m
ob
ili
ty
 ti
m
e 
(s
) 2
-6
m
in
 
WT En1-Cre
0
100
200
300
Im
m
ob
ili
ty
 ti
m
e 
(s
)
WT En1-Cre
0
2
4
6
D
is
ta
nc
e 
(m
)
WT En1-Cre
0
5
10
15
20
25
Im
m
ob
ili
ty
 E
pi
so
de
s
a b
Im
m
ob
ili
ty
 ti
m
e 
(s
) 2
-6
m
in
 
c d
43 
 
 
Figure 12. En1-Cre mice do not have anxiety-like behaviour in the elevated plus 
maze. (a) Percentage of time spent in the close and open arms as well as the centre of 
the elevated plus maze. (b) Total number of entries into the open arm of the elevated 
plus maze. Data expressed as mean ± SEM. (a) Analyzed using a two-way ANOVA 
and (b) analyzed using a Student’s t-test. WT n = 13, En1-cre n = 10. 
Finally, to assess cognitive functioning, we evaluated these mice in the Morris 
water maze (Figure 13) to assess changes to learning and memory. In the spatial version 
of the Morris water maze, the En1-Cre mice were not different from the WT mice in their 
latency to find the hidden platform over the four acquisition days of this test (F(1,16) = 
0.89, p = 0.3595; Fig. 13a). During the probe trial, there was no significant difference 
between the two genotypes in their time spent in each quadrant during the probe trail 
(F(1,16) = 0.04, p = 0.8409; Fig. 13b). Tukey post hoc analysis revealed the both the WT 
mice (p = 0.0041) and the En1-Cre mice (p = 0.0125) spent significantly more time in the 
target zone than the other three quadrants of the tank. Path tracings are representative of 
WT (Fig. 13c) and En1-Cre (Fig. 13d) mice during the probe trial. These data indicate 
that the En1-Cre mice have no deficits in spatial learning and memory.    
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Figure 13. En1-Cre mice show normal learning and memory capabilities in the 
spatial version of the Morris water maze. (a) Latency to find the hidden platform 
during the four acquisition days and (b) percentage of time spent in each quadrant 
of the tank during the probe trial. T = target, L = left of target, R = right of target 
and O = opposite from target. (c) Representative path tracings of WT mice and (d) 
representative path tracings of En1-Cre mice. Target quadrant is the lower left 
segment of the path tracing image. Data expressed as mean ± SEM. (a) Analyzed 
using a repeated measures two-way ANOVA and (b) analyzed using a two-way 
ANOVA. *, p < 0.05, **, p <0.01. WT n = 11, En1-cre n = 8. 
   
Since En1-Cre mice were not different from controls in any of the behavioural 
parameters it was clear that the presence of Cre recombinase under the En1-Promotor did 
not impart any abnormalities on these animals. As such, we next assessed the VAChTEn1-
Cre-flox/flox mice for deficits resulting from the loss of cholinergic signaling from the PPT.  
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5.3 Behavior analysis of of VAChTEn1-Cre-flox/flox mice 
5.3.1 Locomotor activity and neuromuscular functioning  
Since the PPT is thought to be involved in motor control (Alderson et al., 2008; 
Takakusaki 2008), a number of tests for locomotor activity and neuromuscular 
functioning were performed to test whether there will be any behavioural differences 
between control and VAChTEn1-Cre-flox/flox mice. 
Spontaneous locomotor activity was evaluated in an automated locomotor box. 
Mice were allowed to habituate in the box for two hours on Day 1 (short-term 
habituation). Long-term habituation was also measured in the locomotor box over two 
subsequent days. Total distance travelled over the two-hour period was calculated. There 
was no statistical difference between the distance travelled by VAChTEn1-Cre-flox/flox mice 
and control littermates over the two-hour period on Day 1 (F(1,23) = 0.4546, p = 0.5055; 
Fig. 14a) or between their ability to habituate to the locomotor boxes over three days 
(t(1,79) = 1.74, p = 0.9430; Fig. 14b).  In summary, there were no apparent deficits in 
locomotor activity or habituation to a novel environment in the VAChTEn1-Cre-flox/flox mice.  
To further assess neuromuscular function in VAChTEn1-Cre-flox/flox mice, two tests 
were used: the wire hang test and the grip strength test. For both the wire hang (t(19) = 
1.165, p = 0.2585) and grip strength (t(19) = 1.306, p = 0.2073) tests there was no 
statistical difference between VAChTEn1-Cre-flox/flox mice and control littermates (Fig. 14c-
d).  
The accelerating rotarod task was used to assess motor learning. Both VAChTEn1-
Cre-flox/flox mice and control littermates improved the time spent on the rotarod as well as 
distance traveled and there was no significant difference between genotypes in the 
latency to fall (F(1,15) = 0.88, p = 0.3618) or distance travelled (F(1,15) = 0.56, p = 0.3302) 
(Fig. 14e-f).  
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Figure 14. VAChTEn1-Cre-flox/flox mice have normal spontaneous locomotor activity 
and neuromuscular functioning. (a) short-term habituation in locomotor boxes over 
two hours on day 1. (b) long-term habituation over three days, shown by total 
distanced travlled during each day. (c) duration of time on inverted wire mesh and 
(d) force applied by forelimbs to grip a wire. (e) latency to fall of rotarod and (f) 
distance covered during rotarod test. Data expressed as mean ± SEM. (a-b) analyzed 
using repeated measures two-way ANOVA, (c-d) analyzed using a Student’s t-test, 
and (e-f) analyzed using repeated measures two-way ANOVA. (a-d) VAChTflox/flox n 
= 15, VAChTEn1-Cre-flox/flox n = 12, (e-f) VAChTflox/flox n = 10, VAChTEn1-Cre-flox/flox n = 
7. 
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5.3.2 Metabolism and Sleep 
Metabolic activity was measured using metabolic cages over a 48-hour period and 
data from the last 24 hours was analyzed. In these closed system chambers, mice were 
evaluated for oxygen consumption (Fig. 15a), carbon dioxide production (Fig. 15b), 
resting energy expenditure (RER) (Fig. 15c) and heat production (Fig 15d), as well as 
food and water intake (Fig. 15e-f). No significant difference was observed between 
VAChTEn1-Cre-flox/flox mice and VAChTflox/flox controls in their VO2 (F(1,30) = 0.53, p = 
0.4740), VCO2 (F(1,30) = 0.54, p = 0.4667), RER (F(1,30) = 0.12, p = 0.7301) or heat 
production (F(1,30) = 1.57, p = 0.2202), indicating that decreased VAChT expression in 
the PPT did not alter metabolism. Additionally, there was no significant difference 
between genotypes in food (F(1,30) = 0.88, p = 0.3568) or water (F(1,30) = 0.25, p = 
0.6189) consumption. 
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Figure 15. No difference in metabolism between VAChTEn1-Cre-flox/flox mice and 
controls. Metabolic parameters were measured over a 48-hour period, with the data 
from only the last 24 hours analyzed. The light and dark periods are two 
consecutive 12-hour periods within those 24 hours analyzed. (a) oxygen 
consumption, (b) carbon dioxide consumption, (c) resting energy release (RER), (d) 
heat production, (e) food intake and (f) water intake. Data expressed as mean ± 
SEM, and analyzed using a two-way ANOVA. VAChTflox/flox n = 7, VAChTEn1-Cre-
flox/flox n = 10. 
A feature of the metabolic cages is the ability to measure the animal’s sleep 
through assessing time spent immobile in the cage versus time in motion (Guzman et al., 
2013). The number of sleeping bouts, average duration of these bouts, and total time 
spent sleeping was measured for both the light and dark phases of the test. While there 
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was no significant different in the number of sleeping bouts (F(2,45) = 0.66, p = 0.5213; 
Fig. 16a) or the average duration of these bouts (F(1,45) = 0.10, p = 0.9020; Fig. 16c), 
Bonferroni post hoc revealed a significant decrease in the time spent sleeping during the 
dark phase of the test (the animal’s wake cycle) (F(1,45) = 5.14, p = 0.0283; Fig. 16b). This 
data suggests that there may be a role of PPT cholinergic signaling in the regulation of 
sleep-wake cycles. 
  
 
Figure 16. VAChTEn1-Cre-flox/flox mice spend significantly less total time sleeping in the 
dark phase than controls. Sleep parameters were measured over a 48-hour period, 
with the data from only the last 24 hours analyzed. The light and dark periods are 
two consecutive 12-hour periods within those 24 hours analyzed. (a) number of 
sleeping bouts, (b) total time spent sleeping, and (c) average duration of sleeping 
bouts. Data expressed as mean ± SEM, and analyzed using a two-way ANOVA; *, p 
< 0.05. VAChTflox/flox n = 7, VAChTEn1-Cre-flox/flox n = 10. 
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5.3.3 Gait 
We used the CatWalk gait analysis to evaluate any subtle alterations in gait in these 
animals because the PPT is suggested to play a role in gait and posture (Rolland et al., 
2011).  
VAChTEn1-Cre-flox/flox mice (aged 3-6 months) were not significantly different from 
VAChTflox/flox controls in terms of the intensity of their paw print (F(1,56) = 0.05, p = 
0.8186; Fig. 17a), the stride length (F(1,56) = 0.06, p = 0.8030; Fig. 17c) and the overall 
normalcy of the gait (t(14) = 1.269, p = 0.2251; Fig. 17d). However, the VAChTEn1-Cre-
flox/flox mice demonstrated significantly smaller paw area than controls (F(1,56) = 10.32, p = 
0.002; Fig. 17b). Bonferroni postests did not reveal a significant difference between 
geneotypes for the paw area of a specific paw. Having a smaller paw print area suggests 
that the animals are walking either on the sides of the paws or on their toes, which may 
be indicative of slight postural instability. 
 
51 
 
 
Figure 17. Young VAChTEn1-Cre-flox/flox mice have abnormal gait. In young mice (aged 
3-6 months), (a) intensity of paw print, (b) area of paw print, (c) distance between 
two prints from the same paw and (d) percent normalcy were measured. Data 
expressed as mean ± SEM and analyzed using two-way ANOVA except (d) was 
analyzed using a Student’s t-test; *, p < 0.05. VAChTflox/flox n = 8, VAChTEn1-Cre-
flox/flox n = 8.  
Because of this slight change in postural stability, we also followed with a gait 
analysis in older mice (12 months old). The results reflected those seen in the younger 
mice, but the abnormalities were even more profound. That is, old mutant mice showed a 
significant difference from controls in terms of paw area (F(1,44) = 9.34, p = 0.0038; Fig. 
18b) with the area of their print being smaller. Additionally, old VAChTEn1-Cre-flox/flox mice 
were significantly different from age matched VAChTflox/flox controls (F(1,48) = 8.32, p = 
0.0059) in the intensity of their paw print (Fig. 18a). As for stride length, the old 
VAChTEn1-Cre-flox/flox mice interestingly had a significantly longer stride length (F(1,44) = 
7.58, p = 0.0086) than the control mice (Fig. 18c). For intensity, paw area and stride 
length, Bonferroni post hoc did not reveal a significant difference between geneotypes for 
the paw area of a specific paw. However, when the representative index was compared 
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between genotypes, there was not a significant difference (t(11) = 0.8566, p = 0.4099). 
The representative index is a measure of interlimb coordination when compared to 
normal step sequence patterns (Neumann et al., 2009). In short, VAChTEn1-Cre-flox/flox mice 
showed mild gait abnormalities in the CatWalk analysis, which is very sensitive to 
evaluating the gait parameters, but when compared to a representative normal murine 
gait, the overall gait of VAChTEn1-Cre-flox/flox mice did not show to be significantly 
abnormal (Fig. 18d).    
 
Figure 18. Old VAChTEn1-Cre-flox/flox mice have abnormal gait. In old mice (aged 12 
months) (a) intensity of paw print, (b) area of paw print, (c) distance between two 
prints from the same paw and (d) percent normalcy were measured. Data expressed 
as mean ± SEM and analyzed using two-way ANOVA except (d) was analyzed using 
a Student’s t-test; *, p < 0.05. VAChTflox/flox n = 8, VAChTEn1-Cre-flox/flox n = 8.  
 
5.3.4 Psychiatric-like phenotypes 
5.3.4.1 Depression 
 It has been proposed that depression is a result of dysregulation of the cholinergic 
system (Janowsky 1972) but to date, it is unclear which cholinergic nuclei in the brain 
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may be leading to depression symptoms when disturbed. Using the VAChTEn1-Cre-flox/flox 
mice we have the possibility to assess whether depressive-like behaviour is present in 
animals with disruptions in cholinergic signaling from the PPT.  
Depressive-like behaviour was evaluated by using the forced swim test (FST) and 
the tail suspension test (Figure 19). These tests are pharmacologically validated methods 
of assessing behavioural despair or depressive-like behaviour in animals. Immobility is 
interpreted as hopelessness and depressive-like behaviour since rodents given 
antidepressants will swim longer and spend less time immobile. The time spent 
immobile, as well as the total distance swam, in the last 4 minutes of the test were 
measured.  For the tail suspension test, animals will move to escape the aversive 
situation, but a mouse showing increased depressive-like traits will stop struggling and 
hang immobile. Here, the time spent immobile as well as the number of immobility 
episodes was measured.  
VAChTEn1-Cre-flox/flox mice spent significantly less time immobile than controls in 
both tests (forced swimming t(16) = 2.233, p = 0.0402; tail suspension  t(24) = 0.0040, p 
= 0.0040; Fig. 19a and Fig. 19c, respectively). However, the VAChTEn1-Cre-flox/flox mice 
did not swim a greater distance than controls in the forced swim test (t(17) = 1.551, p = 
0.1394; Fig. 19b) or have a greater number of immobility episodes in the tail suspension 
test (t(24) = 0.05978, p = 0.9528; Fig. 19d).  
In summary, the VAChTEn1-Cre-flox/flox mice demonstrate anti-depressive-like 
behaviour in both the forced swim test and tail suspension tests, suggesting that the 
cholinergic signaling from the PPT may be involved in regulating depressive symptoms.  
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Figure 19. VAChTEn1-Cre-flox/flox mice present antidepressive-like behaviour in the 
forced swimming test and the tail suspension test. (a) immobility time in the final 
four minutes of the forced swimming test and (b) total distance swam in the final 
four minutes of the forced swimming test. (c) the total immobility time and (d) the 
number of immobility episodes in the tail suspension test. Data expressed as mean ± 
SEM and analyzed using a Students’ t test; *, p <0.05; **, p <0.01. (a-b) 
VAChTflox/flox n = 7, VAChTEn1-Cre-flox/flox n = 12. (c-d) VAChTflox/flox n = 14, 
VAChTEn1-Cre-flox/flox n = 12.  
5.3.4.2 Anxiety  
Since the VAChTEn1-Cre-flox/flox mice showed an anti-depressive-like phenotype, we 
decided to test the animals for further psychiatric-like behaviours. We assessed anxiety-
like behaviour using a number of tests. First, we used the elevated plus maze. In this test, 
the plus-shaped apparatus has two closed, dark arms and two bright open arms. The 
percentage of time spent on either the open or closed arms, or in the centre, was measured 
(Fig. 20a). Additionally, the number of entries into the open arm was quantified (Fig. 
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20b). Mice with increased anxiety traits will spend more time in the dark, closed arms of 
the maze.   
In the elevated plus maze, VAChTEn1-Cre-flox/flox mice did not differ from controls 
in the amount of time they spent in the closed arms, open arms, or the centre (F(1,81) = 
0.001, p = 0.9400) or in the number of open arm entries (t(27) = 0.5215, p = 0.6063).   
Next, anxiety-like behaviour was evaluated using the locomotor boxes. Mice are 
allowed to explore the boxes freely for a two-hour period. Mice with increased anxiety 
traits will spend more time in the corners of the box, whereas mice with less anxiety traits 
will explore the box and spend more time in the centre. Here, total time in the centre of 
the locomotor was measured (Fig. 20c). Likewise, when time spent in the centre of the 
locomotor boxes was measured, VAChTEn1-Cre-flox/flox mice did not differ from controls 
(t(18) = 0.3276, p = 0.7470). 
Finally, the light/dark place preference test was used as an additional measure of 
anxiety. In this test, a black box with a small entrance is placed inside the locomotor box 
to divide it into two halves: the open half and the dark covered half. The percent of time 
spent in the dark versus the light portion of the box was measured (Fig 20d). 
Surprisingly, in the light/dark place preference test, VAChTEn1-Cre-flox/flox mice spent a 
significantly greater time in the dark than littermate controls (t(26) = 2.401, p = 0.0238). 
In summary, results from the light/dark place preference task suggested that  
VAChTEn1-Cre-flox/flox mice show increased anxiety-like behaviour phenotype, however, in 
the other two tests, the partial loss of cholinergic signaling from the PPT did not appear 
to affect anxiety-like behaviour.  Together these results suggest that if VAChTEn1-Cre-
flox/flox mice show an anxiety phenotype, it does not seem to be a robust phenotype. 
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Figure 20. VAChTEn1-Cre-flox/flox mice demonstrate an anxiety-like phenotype in the 
light/dark place preference test. (a) Percentage of time spent on the closed or open 
arms or the centre of the elevated plus maze and (b) the number of entries into the 
open arm of the elevated plus maze. (c) Total time spent in the centre of a locomotor 
box during a two-hour period. (d) Percentage of time spent in the dark chamber 
during the light/dark place preference test. (a) Data expressed as mean ± SEM and 
analyzed using a two-way ANOVA and (b-d) data analyzed using a Students’ t test; 
*, p < 0.05. (a-b) VAChTflox/flox n = 14, VAChTEn1-Cre-flox/flox n = 15. (c) VAChTflox/flox n 
= 8, VAChTEn1-Cre-flox/flox n = 12. (d) VAChTflox/flox n = 16, VAChTEn1-Cre-flox/flox n = 12.  
5.3.4.3 Compulsivity 
To further characterize potential psychiatric-like behaviours of these VAChTEn1-
Cre-flox/flox mice, we next assessed compulsivity or repetitive behaviours using the marble 
burying task (Fig. 21). Here, twenty marbles are even spaced on top of two inches of 
clean bedding in a novel cage. Mice were place in the cage for fifteen minutes and the 
number of marbles buried in the bedding was quantified.  Mice that buried a greater 
number of marbles were considered to have more perseverative behaviour.  
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VAChTEn1-Cre-flox/flox mice buried significantly less marbles then VAChTflox/flox 
control mice (t(31) =2.077, p = 0.0462), suggesting that these mice show decreased 
compulsivity compared to controls. 
 
Figure 21. VAChTEn1-Cre-flox/flox mice have decreased compulsive behaviours in the 
marble burying task. VAChTEn1-Cre-flox/flox mice buried less marbles than controls in 
the marble burying task. Data expressed as mean ± SEM and analyzed using a 
Student’s t-test; *, p < 0.05. VAChTflox/flox n = 19, VAChTEn1-Cre-flox/flox n = 19.  
 
5.3.5 Learning and Memory 
5.3.5.1 Spatial memory 
We tested spatial learning and memory in the VAChTEn1-Cre-flox/flox mice using the 
MWM (Fig. 22). For the spatial version of this test, mice undergo 4 days of training (the 
acquisition phase) to learn the location of a hidden platform. On the fifth day, the probe 
trial occurs and the amount of time spent in each quadrant of the tank with the platform 
removed is quantified.   
During the course of acquisition, performance of VAChTEn1-Cre-flox/flox mice was 
significantly different from that of controls in terms of latency to find the target (F(1,22) = 
5.33, p = 0.0307; Fig. 22a). Bonferroni post hoc test analysis demonstrated that the 
VAChTEn1-Cre-flox/flox mice did not improve their latency to find the target on days 3 and 4 
during the acquision phase.  VAChTEn1-Cre-flox/flox mice took the same time to find the 
hidden platform across the four acquisition days, whereas VAChTflox/flox control mice 
were able to find the platform more quickly each successive day. These results indicated 
that VAChTEn1-Cre-flox/flox mice had deficits in learning the location of the platform. On the 
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probe trial day, VAChTEn1-Cre-flox/flox mice showed no preference for the target quadrant of 
the pool whereas the Tukey post hoc test demonstrated that the VAChTflox/flox control 
mice spent significantly more time in the target quadrant (r = 0.4666, p < 0.0001) (Fig. 
22b). The occupancy plots for the probe trial show that the controls remembered where 
the platform should be and spent the majority of their time in this quadrant (Fig. 22c). In 
contrast, VAChTEn1-Cre-flox/flox mice did not seem to recall this location during the probe 
trial and primarily spent their time in thigmotaxis or passive floating  (Fig. 22d).  
 
Figure 22. VAChTEn1-Cre-flox/flox mice show deficits in learning and memory in the 
spatial version of the Morris water maze. (a) Latency to find hidden platform over 4 
training days during of the spatial Morris water maze and (b) time spent in each 
quadrant during probe trial; T=target, L=left of target, R=right of target and 
O=opposite from target. (c) Representative plots of flox/flox mice during the probe 
trial and (d) representative plots of VAChTEn1-Cre-flox/flox mice during the probe trial. 
The target quadrant is the bottom right segment of the path tracing images. Data 
expressed as mean ± SEM and analyzed using a two-way ANOVA; *, p < 0.05, **, p 
<0.01, ***, p < 0.0001. VAChTflox/flox n = 12, VAChTEn1-Cre-flox/flox n = 12. 
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5.3.5.2 Goal-directed learning  
We next assessed the ability of VAChTEn1-Cre-flox/flox mice to learn and remember 
the location of a visible platform that was further indicated by a large cue (Vorhees and 
Williams, 2006).  In the cued version of the Morris water maze, mice undergo 8 trials on 
Day 1 (the acquisition phase) to learn to swim to the visible platform, and the location of 
the platform and their starting point changes in each trial. On Day 2, the mice undergo 
two trials but with platform location and starting point combinations they did not 
experience on Day 1.  
During the acquisition day VAChTEn1-Cre-flox/flox mice were significantly different 
from controls (t(14) = 2.611, p = 0.0205) in terms of latency to find the target platform 
(Fig. 23a). This deficit was even more pronounced during the probe trial where 
VAChTflox/flox mice decreased their latency to find the cued platform and VAChTEn1-Cre-
flox/flox mice did not (t(14) = 4.653, p = 0.004; Fig. 23b). Examination of the path traces 
confirmed that VAChTflox/flox mice swam almost directly to the platform (Fig 23c) 
whereas VAChTEn1-Cre-flox/flox mice do not appear to use the cue to find the target on the 
second day (Fig. 23d). 
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Figure 23. VAChTEn1-Cre-flox/flox mice show deficits in learning and memory in the 
cue-directed version of the Morris water maze. (a) Latency to find the visible 
platform during the cued Morris water maze training day (8 trials) and (b) latency 
to find the visible platform during the probe trial (2 trials). (c) Representative plots 
of VAChTflox/flox mice during the probe trial and (d) representative plots of 
VAChTEn1-Cre-flox/flox mice during the probe trial. The target quadrant is the bottom 
segment of the path tracing images; T= Target.  Data expressed as mean ± SEM and 
analyzed using a Student’s t-test; *, p < 0.05; **, p <0.01; ***, p < 0.0001. 
VAChTflox/flox n = 8, VAChTEn1-Cre-flox/flox n = 8.   
5.3.5.3 Working memory 
To further characterize the learning and memory deficits that result from a 
deficiency of cholinergic signaling in the PPT, we used the spontaneous alternations Y-
Maze to evaluate working memory in these animals (Fig. 24) (de Castro et al., 2009).  
  VAChTEn1-Cre-flox/flox mice and control mice had the same number of spontaneous 
alternations (t(23) = 1.912, p = 0.0684; Fig. 24) in the Y maze. Performance of both 
genotypes was above chance (> 50%) regarding alternations, suggesting that these mice 
have no working memory deficit.  
 
 
VAChTflox/flox VAChTEn1-Cre-flox/flox
0
10
20
30
40
50
p = 0.0205
*
Genotype
La
te
nc
y 
(s
)
VAChTflox/flox VAChTEn1-Cre-flox/flox
0
10
20
30
40
50
p = 0.0004
***
Genotype
La
te
nc
y 
(s
)
a b 
c d 
T T T T 
61 
 
 
Figure 24. VAChTEn1-Cre-flox/flox mice have normal working memory in the 
spontaneous alternations Y-maze task. The percent of alternation is shown. Both 
genotypes performed about chance, as indicated by the dashed line. Data expressed 
as mean ± SEM and analyzed using a Students’ t-test. VAChTflox/flox n = 14, 
VAChTEn1-Cre-flox/flox n = 11.  
5.3.6 Attention 
To determine whether VAChTEn1-Cre-flox/flox mice are affected in other cognitive 
domains that are sensitive to cholinergic tone from the PPT, we used the 5-choice serial 
reaction time task (5-CSRTT) (Romberg et al., 2011).  During the training phase, 
VAChTEn1-Cre-flox/flox mice did not differ from controls in terms of number of training 
sessions needed to achieve criterion (F(1,10) = 0.18, p = 0.6819) with a main effect of 
training phase (F(2,20) = 7.12, p = 0.0046; Fig. 25). It should be noted that one mouse of 
each genotype never completed the training phase and thus were removed from the 
experiment and were not subjected to the 5-CSRT task. Mice were first trained using a 4 
s stimulus duration and then we proceeded to 2 s stimulus duration for the 5-CSRT task 
training. VAChTEn1-Cre-flox/flox mice were able to acquire the task, reaching the criteria at 
both stimulus durations (2 and 4 s) in the same number of sessions as controls (F(1,10) = 
0.18, p = 0.6819) with a main effect of training phase (F(2,20) = 7.12, p = 0.0046; Fig. 25). 
During the 5CSRTT training phase, two VAChTflox/flox control mice and one VAChTEn1-
Cre-flox/flox mouse were removed from the test due to their inability to pass the 2s stimulus 
duration phase even after all other mice had completed the 5CSRTT probe trial.   
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Figure 25. Sessions to reach criteria. Number of training sessions required to meet 
the criteria to pass the punish incorrect training phase, the 4s stimulus duration 
training phase or the 2s stimulus duration training phase. Data expressed as mean ± 
SEM and analyzed using a repeated measures two-way ANOVA. VAChTflox/flox n = 
6, VAChTEn1-Cre-flox/flox n = 7.  
For the probe trial, we increased the attentional demand by decreasing the 
stimulus durations to 1.5 s, 1.0 s, 0.8 s and finally 0.6 s. During the probe trials, 
VAChTEn1-Cre-flox/flox mice did not differ from controls in choice accuracy (F(1,10) = 0.02, p 
= 0.8970) and there was a significant effect of stimulus duration (F(3,30) = 6.45, p = 
0.0017; Fig. 26a). The rate of omissions for VAChTEn1-Cre-flox/flox mice was unaffected 
(F(1,10) = 0.14, p = 0.7154) and there was a significant effect of stimulus duration (F(3,20) = 
34.32, p < 0.0001; Fig. 26b). As for premature responses, again VAChTEn1-Cre-flox/flox mice 
were not different from controls (F(1,1o) = 0.81, p = 0.3896; Fig. 26e). No change in 
perseverative responses was observed in VAChTEn1-Cre-flox/flox mice (F(1,10) = 1.04, p = 
0.3314; Fig. 26f). Additionally, VAChTEn1-Cre-flox/flox mice did not differ from controls in 
terms of their correct response latency (F(1,10) = 0.16, p = 0.6950; Fig. 26c). There were 
also no differences between genotypes in terms of reward collection latency (F(1,10) = 0.12, 
p = 0.7376; Fig. 26d). 
In summary, decreased cholinergic signaling from the PPT did not have a 
significant affect on the attentional capacities of these animals as measured by the 5-
CSRTT. 
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Figure 26. VAChTEn1-Cre-flox/flox mice do not show attentional deficits in the 5-choice 
serial reaction time task. (a) Percent correct, (b) percent of omissions, (c) correct 
response latency, (d) reward collection latency, (e) number of premature responses 
and (f) total preservative correct. Data expressed as mean ± SEM and analyzed 
using a two-way ANOVA. VAChTflox/flox n = 6, VAChTEn1-Cre-flox/flox n = 7.  
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Chapter 3  
6 Discussion 
Here we investigated the role of ACh release from PPT cholinergic neurons.  
Decreased cholinergic signaling from the PPT appeared to have no affect on spontaneous 
locomotor activity, neuromuscular functioning, metabolism, working memory or 
attention.  A small but significant effect on gait and sleep was observed. VAChTEn1-Cre-
flox/flox mice had strong deficits in learning spatial cues in the Morris water maze and 
showed deficits in goal-directed behaviours.  Additionally, an antidepressive-like 
behaviour, a slight anxiety-like behaviour and reduced compulsivity were observed in 
these animals.  These results suggest that ACh has an important role in the modulation of 
several of the physiological functions regulated by the PPT. 
6.1 Analysis of VAChTEn1-Cre-flox/flox mice 
 We used the Rosa26-tdTomato reporter mice to elucidate the pattern of expression of 
Cre recombinase driven by the En1 promoter. Our immunohistological analysis of brain 
slices of these reporter mice revealed expression patterns of Cre recombinase that varied 
slightly from those previously reported by Patel et al. (2012). These authors found Cre-
expression under the En1-Cre driver restricted to the rostral brainstem, and crossing of 
En1-Cre mice with ChATflox/flox mice resulted in a complete loss of ChAT mRNA 
expression in the PPT and LDT, as measured by in-situ hybridization. Here, we found 
that approximately 40% of CHT1-labelled cholinergic neurons colocalized with neurons 
expressing tdTomato, suggesting that around 40% of cholinergic neurons within the PPT 
would have a loss of VAChT and subsequently be unable to release ACh, in contrast to 
the 100% decrease in ChAT mRNA observed in the En1-Cre;ChATflox/flox mice. 
Additionally, we did observe that approximately 10% of cholinergic neurons in the Mo5 
motor nuclei colocalized with neurons expressing tdTomato, while Patel and colleagues 
(2012) reportated that Mo5 was unaffected. Importantly, these authors created En1-
Cre;Tau reporter mouse line to determine the neuronal populations affected by Cre-
recombinase. One En1-Cre;Tau sagittal brain section from one mouse was stained by 
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immunohistochemistry for nuclear β –galactosidase (nLacZ) and VAChT. The image was 
included, however no quantification of colocalization between nLacZ- and VAChT-
labelling was provided, and visual examination of the image indicates much less than 
100% of the VAChT-labelled neurons colocalize with the nLacZ-labelled neurons, as was 
observed in our immunohistological analysis   Importantly, Patel et al., (2012) did not 
investigate the protein levels of ChAT in the PPT and the neuronal populations it 
innervates to indirectly quantify the extent of Cre-mediated recombination.  Our Western 
blot analysis showed that the thalamus, the primary output centre of the PPT, had an 
almost 100% decrease in VAChT levels. As projections from the PPT are the major 
source of ACh to the thalamus (Kotegal et al., 2012), these results strongly indicate that 
most cholinergic projections from the PPT to the thalamus did not have VAChT in their 
nerve terminals. While the Western blot analysis supports that the decrease in VAChT 
expression is restricted to the rostral brain, the immunohistological analysis indicates that 
these mice have only a partial decrease in VAChT expression, and subsequently 
cholinergic signaling, in the PPT.  
6.1.1 Locomotion and gait 
VAChTEn1-Cre-flox/flox mice showed normal spontaneous locomotor activity in an open 
field, no muscular weakness in the grip strength or wire hang test, and their performance 
in the rotarod task was not significantly different from controls, indicating that these 
mutants were physically fit. These data indicate that the release of ACh from the 
cholinergic neurons of the PPT is not required for spontaneous locomotor activity or 
neuromuscular functioning.  
Previous studies using lesions of the PPT to examine the effects of PPT signaling on 
spontaneous locomotion have found similar results. Steiniger and Kretschmer (2004) 
found that bilateral lesions of the PPT had no effect on spontaneous motor behaviour in 
rats. Hernandez-Chan et al. (2011) also found that bilateral lesions of the PPT with 
quinolinic acid failed to produce changes in motor activity. However, these lesions 
eliminated not only cholinergic, but also glutamatergic and GABAergic neurons from the 
PPT. Different from our results, Patel and colleagues (2012) who evaluated locomotor 
activity in conditional ChAT knockout mice using the En1-Cre driver, suggested that the 
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En1Cre; ChATflox/flox mice were hypoactive. Like the VAChTEn1-Cre-flox/flox mice, the En1Cre; 
ChATflox/flox mice showed loss of cholinergic activity in the PPT (Patel et al., 2012). One 
possible explanation for the hypolocomotion phenotype observed in En1Cre; 
ChATflox/floxmice is the different background.  Although Patel et al. (2012) did not report 
the background of the mice they used in their studies, it is possible that they were mainly 
129S1/SvImJ, as the En1Cre mice (Jax stock# 007916) are provided from Jax Laboratories 
in this background. Mice on a different 129 background, including 129S1/SvImJ, 
129S6/SvEvTac, and 129X1/SvJ, have been reported to be hypoactive when compared to 
mice in C57Bl/6 background (Thomsen et al., 2011). For our studies, we initially 
backcrossed the En1Cre mice twice to a C57Bl/6 background before we crossed them to 
the VAChTflox/flox mice. Thus, in the VAChTEn1-Cre-flox/flox mice the C57Bl/6 background 
predominates over the 129S1. Additionally, our experiments with the VAChTEn1-Cre-
flox/flox mice indicate that these mice travel 300 m in the first 10 minutes of the 
spontaneous locomotion in an open field test, which is the same distance travelled for the 
En1Cre; ChATflox/flox in the first 10 minutes of the open field test that Patel et al. (2012) 
performed. It is possible that the reason the En1Cre; ChATflox/flox mice are hypoactive 
compared to controls is that the authors used an unknown combination of Nkx2.1Cre, 
En1Cre and ChATflox/+ mice as controls. It has been shown in our lab that Nkx2.1Cre mice 
have greater spontaneous locomotor activity than the En1Cre mice (unpublished data).  
Our finding that cholinergic tone from the PPT does not influence neuromuscular 
functioning, as measured by the rotarod task, is supported by a study by Machold (2013). 
Machold (2013) tested En1Cre; ChATflox/flox mice on an accelerating rotarod , and found no 
significant difference btween these mice and controls in the latency to fall off the rotarod 
over the two consecutive days of training. As these En1Cre; ChATflox/flox mice also have a 
deficit in cholinergic signaling from the PPT, these data support our finding that ACh 
release from the PPT is not involved in motor control.  
The PPT is thought to have a role in the initiation and maintenance of gait (Garcia-
Rill 1991; Winn 2006; Karachi et al., 2010) and lesions of the PPT cause abnormalities in 
gait (Karachi et al., 2010). Importantly, PD and PSP are accompanied by approximately 
40% cholinergic neuron loss in the PPN (Hirsch et al., 1987, Zweig et al., 1989), and 
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different studies have suggested that a loss of cholinergic signaling from the PPN causes 
physical abnormalities in PD and PSP patients.  For instance, PET studies of PD patients 
with several postural instability leading to falls had significantly less cholinergic 
innervation in the thalamus from the PPN than non-fallers (Bohnen et al., 2009; 2012). 
PSP patients have an even greater loss of thalamic cholinergic activity in combination 
with more severe balance impairments and falls than PD patients (Hirsch et al., 1987; 
Wenning et al, 1999). The motor symptoms of PD (gait freezing and postural instability) 
remain unaffected by dopamine replacement therapy with levodopa suggesting that these 
symptoms are not a result of the loss of dopaminergic signaling in these individuals 
(Pahapill and Lozano, 2000; Fernandez 2012). On the other hand, the anticholinesterase 
inhibitor donepezil reduced the number of falls in frequently falling PD patients (Chung 
et al., 2010).  We observed deficits on gait parameters in VAChTEn1-Cre-flox/flox mice using 
the CatWalk gait analysis system. In both young mice (3-6 months of age) and old mice 
(12 month of age), the animals walked with a decreased paw area. This is indicative of a 
slight postural instability as a decreased paw area could suggest that the VAChTEn1-Cre-
flox/flox mice are walking on the sides of their paws or on their toes. Thus, our data give 
further support to the hypothesis that cholinergic signaling from the PPT is important for 
modulation of gait. 
6.2 Psychiatric-like phenotypes 
The cholinergic system has long been thought to play an important role in the 
etiology of depression (Janowsky 1972).  This hypothesis has been supported by a 
number of animal and clinical studies. For instance, Mineur et al. (2013) showed that 
physostigmine-injected mice spent significantly more time immobile in the tail 
suspension test than controls, suggesting that the increased cholinergic tone in the brain 
resulted in this depressive-like behaviour. Physostigmine, is a AChE inhibitor used to 
increase cholinergic tone in the brain. In contrast, administration of nAChR antagonists 
(such as mecamylamine) to mice to cause a global decrease in cholinergic tone in the 
brain, results in an antidepressive-like phenotype in both the forced swim test and the tail 
suspension test (Andreasen 2008). Additionally, knockout mice lacking 2 subunit-
containing nAChRs spend less time immobile in the tail suspension test and forced 
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swimming test, indicating that decreased cholinergic signaling via nAChRs may 
contribute to an antidepressive-like phenotype in mice (Caldarone et al., 2004). In all, it is 
clear that brain cholinergic tone is involved in depressive-like behaviour, but the 
mechanisms and specific cholinergic nuclei involved are not known. Our results suggest 
that ACh released from the PPT, at least in part, might be mediating the effects of 
depression. In both the forced swim test and the tail suspension test, the VAChTEn1-Cre-
flox/flox mice spent significantly less time immobile than the VAChTflox/flox control mice. 
This decrease in immobility time is indicative of an antidepressive-like phenotype in 
these animals. This suggests that the decreased cholinergic signaling from the PPT is 
responsible for the antidepression-like behaviour in these animals. 
Interestingly, previous PPT lesion studies have revealed a surprising connection 
between the PPT and another psychiatric-like behaviour: anxiety. Several studies have 
reported increased anxiety-like behaviour in rodents after PPT lesions. Anxiety in 
animals is evaluated by comparing their avoidance behaviour in the presence of putative 
anxiogenic stimuli (for example walled vs. open arms and dark vs. light compartments) 
(Dere et al., 2002). NMDA-induced PPT lesions, as well as bilateral electrolytic lesions 
of the PPT have produced increased anxiety-like behaviours in the elevated plus maze 
test (Leri and Franklin 1998; Podhorna and Franklin 1999). In contrast, Homs-Ormo et al 
(2002) tested bilateral electrolytic lesions of the PPT on the behaviour of rats in the 
elevated plus maze and found that there was no difference between the lesioned animals 
and the sham animals during this task. The contrasting results obtained in these lesion 
studies are likely due to the differing populations of neurons targeted by the lesion, and to 
date, no studies have specifically isolated the role of ACh release from the PPT on 
murine anxiety. In this study, we observed that cholinergic signaling from the PPT do not 
seem to have strong influence in the regulation of anxiety as deletion of VAChT in the 
PPT led to deficits in the light/dark place preference test, but did not lead to deficits in the 
elevated plus maze or the time in spent in the centre of the open field arena.  
In the literature, the marble-burying assay has been used to evaluate either anxiety-
like and/or repetitive-like behaviours (Thomas et al., 2009). Interpretation of this test can 
consider the burying behaviour as an anxiety-like behaviour in response to a novel 
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stimuli, or as a obsessive/compulsive-like behaviour (Thomas et al., 2009). If viewed 
through through the anxiety-like behavior paradigm, these data suggest that the decrease 
in cholinergic tone from the PPT results in decreased anxiety-like behaviour in this test. 
While this result is in contrast to the results obtained in other measures of anxiety-like 
behaviour in this study, it has been shown that antidepressants decrease marble burying 
behaviour (Li et al., 2006), so its possible that this phenotype is an artifact of the 
antidepressive-like behaviour seen in the VAChTEn1-Cre-flox/flox animals. Thomas et al. 
(2009) propose that marble burying reflects a perseverative behaviour more than novelty-
induced anxiety. If considered in this manner, the loss of cholinergic tone in the PPT 
results in decreased repetitive behaviours. In terms of the role of cholinergic signaling 
from the PPT in compulsivity or perseverative behaviours, little is known. The present 
finding that mice lacking cholinergic signaling from the PPT have a decreased 
compulsive-like phenotype in the marble burying task is novel.  Ahmari and collegues 
(2013) used optogenetics in mice to stimulate the ventral striatum and hyperactivate the 
cortico-striatal-thalamic-cortico (CSTC) circuit, and found that this resulted in a 
persistent increase in grooming, which is a mouse behaviour related to OCD. The PPT 
has direct influence on this circuitry (Winn 1998), so it is possible that the loss of 
cholinergic input to the CSTC results in the decreased compulsive-like behaviours seen in 
the VAChTEn1-Cre-flox/flox animals during the marble burying task. Additionally, a feature of 
the 5-choice serial reaction time task is that it also provides a means of evaluating 
perseverative behaviour in the animals. During the probe trial with a 0.8 s stimulus, the 
VAChTEn1-Cre-flox/flox mice show a strong trend towards a decreased perseverative response 
compared to controls. However, the 5-CSRTT does not adequately measure attention and 
compulsivity simultaneously.  This trend requires further investigation as changing the 
parameters of the 5-CSRTT and increasing the number of mice used in the study may 
reveal a decreased-compulsivity phenotype in these animals that would support the 
results seen in the marble burying task.  
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6.3 Attention, sleep and cognition 
The PPT has very strong reciprocal connections to the corticostriatal circuits, so it is 
often thought to be involved in many higher cognitive functions such as learning, 
memory and attention (Mena-Segovia et al., 2004).  
It has been shown that the PPT has an important role in the regulation of working 
memory (Keating and Winn 2002; Taylor et al. 2004). Taylor et al. (2004) used the 
delayed spatial win-shift (DSWS) radial maze task to evaluate working memory and 
found that rats with bilateral electrolytic PPT lesions performed significantly worse than 
the sham lesion rats, making about four errors per test compared to the average rate of 
less than one error per test for the sham operated rats. VAChTEn1-Cre-flox/flox mice did not 
show any differences in performance from the littermate controls when we evaluated 
working memory using the spontaneous alternations Y-Maze, suggesting that the PPT 
cholinergic tone is not important for working memory function. Taken together, these 
results indicate that the working memory deficits observed in studies using PPT lesions 
(Keating and Winn 2002; Taylor et al. 2004) are due to the loss of glutamatergic and 
GABAergic signaling from the PPT. Alternatively, since the VAChT ablation is not in 
100% of PPT cholinergic neurons, there is the possibility that some of the specific 
cholinergic neurons involved in working memory have not been affected by Cre-
mediated recombination and thus working memory is not affected in these animals.  
When spatial learning and memory was evaluated using the spatial version of the 
Morris water maze (MWM), VAChTEn1-Cre-flox/flox mice showed a strong impairment in 
spatial navigation during the spatial version of the MWM, with a greater latency to find 
the platform than controls during the acquisition phase, and no preference for the target 
zone during the probe trial.  Stackman and Lora et al. (2012) showed that inactivation of 
the anterior thalamic nuclei with muscimol resulted in deficits in the performance of mice 
in the spatial MWM.  The PPT has direct cholinergic afferents to the ATN (Gonzalo-Ruiz 
et al., 1995) and with the cholinergic signaling from the PPT to the thalamus almost 
abolished in the VAChTEn1-Cre-flox/flox mice, its possible that the cholinergic input to the 
thalamus from the PPT is necessary for spatial memory. Another possible interpretation 
of deficits of the VAChTEn1-Cre-flox/flox mice in the spatial MWM is that the cholinergic 
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signaling from the PPT is important for learning. The DSWS maze used by Taylor and 
colleagues (2004) was used to evaluate working memory, but this test is also very 
challenging to an animal’s ability to use spatial cues. In the first stage of training in the 
DSWS maze, all four arms of the maze are open and there is no reward, there is no 
impairment of the lesioned animals’ performance (Taylor et al., 2004). This apparatus is 
similar to the Y-maze used in this study, where there are three open arms of the maze for 
the animal to explore. It is only when the difficulty of the DSWS task is increased (by 
changing the arms of the maze that contain the reward) that the lesioned animals present 
impairments (Taylor et al., 2004). This suggests that it may not be working memory that 
is affected by the PPT lesion, but their ability to learn. This explanation accounts for a 
normal working memory in the Y-maze (where no training is involved) but impaired 
learning of the location of the escape platform in the MWM in the VAChTEn1-Cre-flox/flox 
mice.  
To explore goal-directed learning in the VAChTEn1-Cre-flox/flox mice further, the goal-
directed version of the Morris water maze was used. This version of the Morris water 
maze uses a similar paradigm to the DSWS task where animals must swim to a platform 
indicated by a cue in 8 different positions to receive the reward of being removed from 
the tank of water. On the testing day, the combination of the animal’s starting location 
and the location of the cued-platform was one that was not used during the acquisition 
phase. Here, we saw significant deficits in goal-directed learning in the cued version of 
the MWM. Mice lacking cholinergic tone in the PPT showed significantly greater 
latencies to find the platform during the acquisition phase than the control mice, and an 
even greater deficit during the testing phase.  This deficit in goal-directed behaviour was 
further emphasized by the VAChTEn1-Cre-flox/flox mouse their path traces, which indicate 
that the mice often swam in thigmotaxis, which is correlated with stress and anxiety in 
animals (Graziano et al., 2003).  This swimming strategy was also observed in the spatial 
version of the MWM. Since the escape platform in this test is visible to the mice by a 
very obvious cue, the mice do not have to use their spatial learning and memory skills to 
locate it in the tank. The inability of the VAChTEn1-Cre-flox/flox mice to learn the location of 
the platform in both the spatial and cued versions of the MWM strongly suggests that the 
release of ACh from the PPT is critical for learning.  
72 
 
Finally, attention was evaluated in these mice using the 5-CSRTT. Our data 
demonstrates that the VAChTEn1-Cre-floxflox mice were unhindered in their ability to learn 
the conditions of each pre-training phase and subsequently required the same number of 
sessions to meet the criteria to pass the pre-training phase as the control mice did. While 
the VAChTEn1-Cre-flox/flox mice are not significantly different from controls in their ability 
to learn the requirements of the 5-CSRTT training phases, there is a trend that the 
VAChTEn1-Cre-floxflox mice required more training days to meet the criteria to pass the 4s 
stimulus training phase. Increasing the number of mice performing the 5-CSRTT may 
reveal a learning deficit at this training phase.  During the 5-CSRTT probe trial, the mice 
did not demonstrate any attentional deficits as their accuracy and number of omissions 
were not significantly different from controls. Inglis et al (2000) reported global 
attentional deficits in rats with bilateral PPT lesions in the 5-CSRTT, which were 
alleviated by decreasing the attentional demands of the test. As our results suggest that 
cholinergic efferents from the PPT do not seem to be required for normal attention 
processes, it is possible that the glutamatergic and GABAergic neurons in the PPT that 
were lesioned in addition to cholinergic neurons were responsible for the deficits 
observed by Inglis and colleagues. It is also possible that a sub-population of cholinergic 
efferents spared in VAChTEn1-Cre-flox/flox could be responsible for the intact attentional 
performance.  
6.4 Limitations 
The primary limitation of this study is that these animals are born with the decreased 
cholinergic tone in the PPT and as a result they may develop compensatory mechanisms 
in the brain during development. The engrailed (En) homeobox 1 transcription factor is 
crucial for the formation of the midbrain [mesencephalon (mes)] and anterior hindbrain 
[rhombomere (r1)] during embryonic development (Sgaier et al., 2007). En1 acts at the 
mid-hindbrain junction between embryonic day 8.5 and 13, so Cre-mediated 
recombination was occurring during the initial formation of this brain structure.  In this 
study, it is not possible to determine if the observed altered behaviours are due singularly 
to the loss of cholinergic signaling from the PPT, or from the combination of 
compensatory changes that have occurred since birth.  
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6.5 Future directions 
To further expand on the results from this study, it would be of value to continue to 
characterize the  compulsive-like behaviours seen in the VAChTEn1-Cre-flox/flox mice. By 
increasing the number of  mice used in the 5-CSRTT and by changing the parameters of 
the test to test for perseverative behaviours, it would confirm if the trend towards a 
decreased perseverative behaviour is in fact a phenotype for the  VAChTEn1-Cre-flox/flox 
mice that reflects the decreased compulsive-like behaviours seen in these animals in the 
marble burying task.  
Additionally, it is necessary to account for any compensatory mechanisms that 
may have occurred in the VAChTEn1-Cre-flox/flox mice as the decrease in cholinergic tone 
was present since early embryonic development. For future studies, a Cre recombinase 
virus will be injected into the PPT of adult VAChTflox/flox mice and the behavioural tests 
will be repeated in order to identify any effects from this potential compensation.  
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Chapter 4  
7 Conclusions 
The present data provide evidence for the role of cholinergic signaling from the 
pedunculopontine tegmental nucleus as the mice used in this study provide a novel means 
of selectively reducing ACh release from the PPT without damaging the cholinergic 
neurons or altering their potential release of other neurotransmitters/modulators.  The 
present findings from this study suggest that ACh signaling from the PPT is important for 
the mediation of depressive-like symptoms and learning and memory, and to a lesser 
extent, gait, anxiety-like symptoms, sleep and perseverative-like behaviours.  These data 
contribute to our current understanding of depression, Parkinson’s disease and 
progressive supranuclear palsy. While the idea that dysregulation of the cholinergic 
system may contribute to the etiology of major depressive disorder is not novel, to date, 
no specific cholinergic nuclei have been implicated. Here, we present data that implicates 
cholinergic signaling from the PPT, at least in part, in depressive symptoms. As such, 
pharmacological agents that limit ACh signaling from the PPT may have the potential to 
ameliorate some of the symptoms of major depressive disorder, and thus lead to the 
development of novel antidepressant medications.  
Additionally, these data emphasize the role of the PPT in the pathophysiology of 
PD and PSP. Some of the symptoms of these neurodegenerative diseases, such as gait 
abnormalities, postural instability and falls are not improved by traditional DA treatment 
(Nandi et al., 2012). Our data suggest that it is possible that PPT degeneration is also 
responsible for some cognitive impairments of PD. For instance, motor symptoms of PD 
are often preceded by sleep disturbances (Takakusaki et al., 2011), which may be due to 
altereded PPT cholinergic signaling and subsequent alterations in sleep-wake cycles, as 
seen in the VAChTEn1-Cre-flox/flox mice.  PD patients also often experience dementia 
(Bohnen et al., 2011), which may be due to PPT degeneration, as the data from this study 
suggest that intact PPT ACh release is necessary for learning and memory. The findings 
from this study further support the role of decreased cholinergic signaling from the PPT 
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in the symptoms of PD, and indicate the PPT as a potential target for deep brain 
stimulation to treat some PD patients. 
As the decrease in cholinergic tone was present in VAChTEn1-Cre-flox/flox since early 
development it not possible to rule out the possibility that the effects observed result from 
compensatory changes. For future studies, a  Cre recombinase virus will be injected into 
the PPT of adult VAChTflox/flox mice.  
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